{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T15:16:00Z","timestamp":1793718960900,"version":"4.6.1"},"reference-count":549,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The pancreas, an organ with dual functions, regulates blood glucose levels through the endocrine system by secreting hormones such as insulin and glucagon. It also aids digestion through the exocrine system by secreting digestive enzymes. Complex interactions and signaling mechanisms between the endocrine and exocrine functions of the pancreas play a crucial role in maintaining metabolic homeostasis and overall health. Compelling evidence indicates direct and indirect crosstalk between the endocrine and exocrine parts, influencing the development of diseases affecting both. From a developmental perspective, the exocrine and endocrine parts share the same origin\u2014the \u201ctip-trunk\u201d domain. In certain circumstances, pancreatic exocrine cells may transdifferentiate into endocrine-like cells, such as insulin-secreting cells. Additionally, several pancreatic diseases, including pancreatic cancer, pancreatitis, and diabetes, exhibit potential relevance to both endocrine and exocrine functions. Endocrine cells may communicate with exocrine cells directly through cytokines or indirectly by regulating the immune microenvironment. This crosstalk affects the onset and progression of these diseases. This review summarizes the history and milestones of findings related to the exocrine and endocrine pancreas, their embryonic development, phenotypic transformations, signaling roles in health and disease, the endocrine-exocrine crosstalk from the perspective of diseases, and potential therapeutic targets. Elucidating the regulatory mechanisms of pancreatic endocrine and exocrine signaling and provide novel insights for the understanding and treatment of diseases.<\/jats:p>","DOI":"10.1038\/s41392-024-02098-3","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T18:03:19Z","timestamp":1739469799000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Pancreatic endocrine and exocrine signaling and crosstalk in physiological and pathological status"],"prefix":"10.1038","volume":"10","author":[{"given":"Chenglin","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinpeng","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiyuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxue","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9806-0949","authenticated-orcid":false,"given":"Chengcheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7081-2299","authenticated-orcid":false,"given":"Yupei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,14]]},"reference":[{"key":"2098_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/978-90-481-9060-7_2","volume":"690","author":"PS Leung","year":"2010","unstructured":"Leung, P. S. Physiology of the pancreas. Adv. Exp. Med. Biol. 690, 13\u201327 (2010).","journal-title":"Adv. Exp. Med. Biol."},{"key":"2098_CR2","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.2337\/db16-1477","volume":"66","author":"DK Andersen","year":"2017","unstructured":"Andersen, D. K. et al. Diabetes, pancreatogenic diabetes, and pancreatic cancer. Diabetes 66, 1103\u20131110 (2017).","journal-title":"Diabetes"},{"key":"2098_CR3","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/S1470-2045(08)70337-1","volume":"10","author":"R Pannala","year":"2009","unstructured":"Pannala, R., Basu, A., Petersen, G. M. & Chari, S. T. New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer. Lancet Oncol. 10, 88\u201395 (2009).","journal-title":"Lancet Oncol."},{"key":"2098_CR4","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1053\/gast.2000.19286","volume":"119","author":"D Malka","year":"2000","unstructured":"Malka, D. et al. Risk factors for diabetes mellitus in chronic pancreatitis. Gastroenterology 119, 1324\u20131332 (2000).","journal-title":"Gastroenterology"},{"key":"2098_CR5","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1136\/jcp.55.4.243","volume":"55","author":"S Jolles","year":"2002","unstructured":"Jolles, S. Paul Langerhans. J. Clin. Pathol. 55, 243 (2002).","journal-title":"J. Clin. Pathol."},{"key":"2098_CR6","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1177\/014107688808100718","volume":"81","author":"A Sakula","year":"1988","unstructured":"Sakula, A. Paul Langerhans (1847-1888): a centenary tribute. J. R. Soc. Med. 81, 414\u2013415 (1988).","journal-title":"J. R. Soc. Med."},{"key":"2098_CR7","doi-asserted-by":"publisher","DOI":"10.1172\/JCI142239","volume":"131","author":"GF Lewis","year":"2021","unstructured":"Lewis, G. F. & Brubaker, P. L. The discovery of insulin revisited: lessons for the modern era. J. Clin. Invest. 131, e142239 (2021).","journal-title":"J. Clin. Invest."},{"key":"2098_CR8","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/aja.1000070304","volume":"7","author":"MA Lane","year":"1907","unstructured":"Lane, M. A. The cytological characters of the areas of langerhans. Am. J. Anat. 7, 409\u2013422 (1907).","journal-title":"Am. J. Anat."},{"key":"2098_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1463-1326.2011.01437.x","volume":"13","author":"PJ Lef\u00e8bvre","year":"2011","unstructured":"Lef\u00e8bvre, P. J. Early milestones in glucagon research. Diabetes Obes. Metab. 13 (Suppl. 1), 1\u20134 (2011).","journal-title":"Diabetes Obes. Metab."},{"key":"2098_CR10","first-page":"371","volume":"11","author":"J Baum","year":"1962","unstructured":"Baum, J., Simons, B. E., Unger, R. H. & Madison, L. L. Localization of glucagon in the alpha cells in the pancreatic islet by immunofluorescent technics. Diabetes 11, 371\u2013374 (1962).","journal-title":"Diabetes"},{"key":"2098_CR11","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1210\/endo-71-3-464","volume":"71","author":"SI Mikami","year":"1962","unstructured":"Mikami, S. I. & Ono, K. Glucagon deficiency induced by extirpation of alpha islets of the fowl pancreas. Endocrinology 71, 464\u2013473 (1962).","journal-title":"Endocrinology"},{"key":"2098_CR12","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1038\/1941201a0","volume":"194","author":"B Hellman","year":"1962","unstructured":"Hellman, B., Wallgren, A. & Hellerstrom, C. Two types of islet alpha cells in different parts of the pancreas of the dog. Nature 194, 1201\u20131202 (1962).","journal-title":"Nature"},{"key":"2098_CR13","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1016\/S0140-6736(75)92198-4","volume":"1","author":"JM Polak","year":"1975","unstructured":"Polak, J. M., Pearse, A. G., Grimelius, L. & Bloom, S. R. Growth-hormone release-inhibiting hormone in gastrointestinal and pancreatic D cells. Lancet Lond. Engl. 1, 1220\u20131222 (1975).","journal-title":"Lancet Lond. Engl."},{"key":"2098_CR14","first-page":"5","volume":"200","author":"T H\u00f6kfelt","year":"1975","unstructured":"H\u00f6kfelt, T. et al. Cellular localization of somatostatin in endocrine-like cells and neurons of the rat with special references to the A1-cells of the pancreatic islets and to the hypothalamus. Acta Endocrinol. Suppl. 200, 5\u201341 (1975).","journal-title":"Acta Endocrinol. Suppl."},{"key":"2098_CR15","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1055\/s-0028-1093736","volume":"7","author":"L Orci","year":"1975","unstructured":"Orci, L., Baetens, D., Dubois, M. & Rufener, C. Evidence for the D-Cell of the pancreas secreting somatostatin. Horm. Metab. Res. 7, 400\u2013402 (1975).","journal-title":"Horm. Metab. Res."},{"key":"2098_CR16","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1210\/endo-83-6-1323","volume":"83","author":"JR Kimmel","year":"1968","unstructured":"Kimmel, J. R., Pollock, H. G. & Hazelwood, R. L. Isolation and characterization of chicken insulin. Endocrinology 83, 1323\u20131330 (1968).","journal-title":"Endocrinology"},{"key":"2098_CR17","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/BF00492685","volume":"42","author":"LI Larsson","year":"1974","unstructured":"Larsson, L. I., Sundler, F., H\u00e5kanson, R., Pollock, H. G. & Kimmel, J. R. Localization of APP, a postulated new hormone, to a pancreatic endocrine cell type. Histochemistry 42, 377\u2013382 (1974).","journal-title":"Histochemistry"},{"key":"2098_CR18","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/BF00221800","volume":"156","author":"LI Larsson","year":"1975","unstructured":"Larsson, L. I., Sundler, F. & H\u00e5kanson, R. Immunohistochemical localization of human pancreatic polypeptide (HPP) to a population of islet cells. Cell Tissue Res. 156, 167\u2013171 (1975).","journal-title":"Cell Tissue Res."},{"key":"2098_CR19","unstructured":"Memoir on the pancreas and on the role of pancreatic juice in digestive processes, particularly in the digestion of neutral fat. By Claude Bernard. 1856. Translated by John Henderson. Monogr. Physiol. Soc. 42, 1\u2013131 (1985)."},{"key":"2098_CR20","doi-asserted-by":"crossref","unstructured":"Willy K\u00fchne (1837-1900) general physiologist. JAMA 213, 291\u2013292 (1970).","DOI":"10.1001\/jama.213.2.291"},{"key":"2098_CR21","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1053\/j.gastro.2012.10.056","volume":"144","author":"JA Williams","year":"2013","unstructured":"Williams, J. A. The nobel pancreas: a historical perspective. Gastroenterology 144, 1166\u20131169 (2013).","journal-title":"Gastroenterology"},{"key":"2098_CR22","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1017\/S1138741600005266","volume":"6","author":"VM Klimenko","year":"2003","unstructured":"Klimenko, V. M. & Golikov, J. P. The Pavlov Department of Physiology: a scientific history. Span. J. Psychol. 6, 112\u2013120 (2003).","journal-title":"Span. J. Psychol."},{"key":"2098_CR23","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1073\/pnas.68.6.1264","volume":"68","author":"P Cuatrecasas","year":"1971","unstructured":"Cuatrecasas, P. Insulin-receptor interactions in adipose tissue cells: direct measurement and properties. Proc. Natl Acad. Sci. USA 68, 1264\u20131268 (1971).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2098_CR24","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1073\/pnas.68.8.1833","volume":"68","author":"P Freychet","year":"1971","unstructured":"Freychet, P., Roth, J. & Neville, D. M. Insulin receptors in the liver: specific binding of (125 I)insulin to the plasma membrane and its relation to insulin bioactivity. Proc. Natl Acad. Sci. USA 68, 1833\u20131837 (1971).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2098_CR25","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.2337\/diab.25.12.1154","volume":"25","author":"JM Olefsky","year":"1976","unstructured":"Olefsky, J. M. The insulin receptor: its role in insulin resistance of obesity and diabetes. Diabetes 25, 1154\u20131162 (1976).","journal-title":"Diabetes"},{"key":"2098_CR26","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1210\/endo-100-5-1384","volume":"100","author":"M Kasuga","year":"1977","unstructured":"Kasuga, M., Akanuma, Y., Iwamoto, Y. & Kosaka, K. Effects of fasting and refeeding of insulin receptors and glucose metabolism in rat adipocytes. Endocrinology 100, 1384\u20131390 (1977).","journal-title":"Endocrinology"},{"key":"2098_CR27","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1126\/science.170678","volume":"190","author":"JS Flier","year":"1975","unstructured":"Flier, J. S., Kahn, C. R., Roth, J. & Bar, R. S. Antibodies that impair insulin receptor binding in an unusual diabetic syndrome with severe insulin resistance. Science 190, 63\u201365 (1975).","journal-title":"Science"},{"key":"2098_CR28","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/S0021-9258(19)44468-2","volume":"248","author":"CR Kahn","year":"1973","unstructured":"Kahn, C. R., Neville, D. M. & Roth, J. Insulin-receptor interaction in the obese-hyperglycemic mouse. A model of insulin resistance. J. Biol. Chem. 248, 244\u2013250 (1973).","journal-title":"J. Biol. Chem."},{"key":"2098_CR29","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1210\/jcem-47-3-590","volume":"47","author":"ND Neufeld","year":"1978","unstructured":"Neufeld, N. D., Kaplan, S. A., Lippe, B. M. & Scott, M. Increased monocyte receptor binding of [125I]insulin in infants of gestational diabetic mothers. J. Clin. Endocrinol. Metab. 47, 590\u2013595 (1978).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2098_CR30","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/0006-291X(71)90604-8","volume":"44","author":"P Cuatrecasas","year":"1971","unstructured":"Cuatrecasas, P., Desbuquois, B. & Krug, F. Insulin-receptor interactions in liver cell membranes. Biochem. Biophys. Res. Commun. 44, 333\u2013339 (1971).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2098_CR31","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/0002-9343(66)90079-9","volume":"41","author":"JE Sokal","year":"1966","unstructured":"Sokal, J. E. Glucagon-an essential hormone. Am. J. Med. 41, 331\u2013341 (1966).","journal-title":"Am. J. Med."},{"key":"2098_CR32","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/0026-0495(78)90066-5","volume":"27","author":"S Raptis","year":"1978","unstructured":"Raptis, S., Schlegel, W., Lehmann, E., Dollinger, H. C. & Zoupas, C. Effects of somatostatin on the exocrine pancreas and the release of duodenal hormones. Metabolism 27, 1321\u20131328 (1978).","journal-title":"Metabolism"},{"key":"2098_CR33","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/0026-0495(78)90064-1","volume":"27","author":"W Creutzfeldt","year":"1978","unstructured":"Creutzfeldt, W. & Arnold, R. Somatostatin and the stomach: exocrine and endocrine aspects. Metabolism 27, 1309\u20131315 (1978).","journal-title":"Metabolism"},{"key":"2098_CR34","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1136\/jcp.s1-8.1.43","volume":"8","author":"TE Adrian","year":"1978","unstructured":"Adrian, T. E. Pancreatic polypeptide. J. Clin. Pathol. Suppl. 8, 43\u201350 (1978).","journal-title":"J. Clin. Pathol. Suppl."},{"key":"2098_CR35","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1080\/003655100448446","volume":"60","author":"JH Henriksen","year":"2000","unstructured":"Henriksen, J. H. & de Muckadell, O. B. Secretin, its discovery, and the introduction of the hormone concept. Scand. J. Clin. Lab. Invest. 60, 463\u2013471 (2000).","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"2098_CR36","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s00535-003-1235-3","volume":"38","author":"WY Chey","year":"2003","unstructured":"Chey, W. Y. & Chang, T.-M. Secretin, 100 years later. J. Gastroenterol. 38, 1025\u20131035 (2003).","journal-title":"J. Gastroenterol."},{"key":"2098_CR37","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s00424-024-02906-3","volume":"476","author":"P Berg","year":"2024","unstructured":"Berg, P., Svendsen, S. L., Ayasse, N., Sorensen, M. V. & Leipziger, J. Secretin: a hormone for HCO3- homeostasis. Pflug. Arch. 476, 545\u2013554 (2024).","journal-title":"Pflug. Arch."},{"key":"2098_CR38","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1152\/ajplegacy.1928.86.3.599","volume":"86","author":"AC Ivy","year":"1928","unstructured":"Ivy, A. C. & Oldberg, E. A hormone mechanism for gall-bladder contraction and evacuation. Am. J. Physiol. Leg. Content 86, 599\u2013613 (1928).","journal-title":"Am. J. Physiol. Leg. Content"},{"key":"2098_CR39","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/MED.0b013e3280122850","volume":"14","author":"R Chandra","year":"2007","unstructured":"Chandra, R. & Liddle, R. A. Cholecystokinin. Curr. Opin. Endocrinol. Diabetes Obes. 14, 63\u201367 (2007).","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"2098_CR40","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3389\/fendo.2017.00047","volume":"8","author":"JF Rehfeld","year":"2017","unstructured":"Rehfeld, J. F. Cholecystokinin\u2014from local gut hormone to ubiquitous messenger. Front. Endocrinol. 8, 47 (2017).","journal-title":"Front. Endocrinol."},{"key":"2098_CR41","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/0012-1606(72)90083-8","volume":"29","author":"RL Pictet","year":"1972","unstructured":"Pictet, R. L., Clark, W. R., Williams, R. H. & Rutter, W. J. An ultrastructural analysis of the developing embryonic pancreas. Dev. Biol. 29, 436\u2013467 (1972).","journal-title":"Dev. Biol."},{"key":"2098_CR42","first-page":"4243","volume":"124","author":"SK Kim","year":"1997","unstructured":"Kim, S. K., Hebrok, M. & Melton, D. A. Notochord to endoderm signaling is required for pancreas development. Dev. Camb. Engl. 124, 4243\u20134252 (1997).","journal-title":"Dev. Camb. Engl."},{"key":"2098_CR43","doi-asserted-by":"publisher","first-page":"4251","DOI":"10.1002\/j.1460-2075.1993.tb06109.x","volume":"12","author":"H Ohlsson","year":"1993","unstructured":"Ohlsson, H., Karlsson, K. & Edlund, T. IPF1, a homeodomain-containing transactivator of the insulin gene. EMBO J. 12, 4251\u20134259 (1993).","journal-title":"EMBO J."},{"key":"2098_CR44","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1101\/gad.12.12.1763","volume":"12","author":"U Ahlgren","year":"1998","unstructured":"Ahlgren, U., Jonsson, J., Jonsson, L., Simu, K. & Edlund, H. beta-cell-specific inactivation of the mouse Ipf1\/Pdx1 gene results in loss of the beta-cell phenotype and maturity onset diabetes. Genes Dev. 12, 1763\u20131768 (1998).","journal-title":"Genes Dev."},{"key":"2098_CR45","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1210\/er.2007-0016","volume":"28","author":"MC J\u00f8rgensen","year":"2007","unstructured":"J\u00f8rgensen, M. C. et al. An illustrated review of early pancreas development in the mouse. Endocr. Rev. 28, 685\u2013705 (2007).","journal-title":"Endocr. Rev."},{"key":"2098_CR46","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1126\/science.1064344","volume":"294","author":"E Lammert","year":"2001","unstructured":"Lammert, E., Cleaver, O. & Melton, D. Induction of pancreatic differentiation by signals from blood vessels. Science 294, 564\u2013567 (2001).","journal-title":"Science"},{"key":"2098_CR47","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00125-004-1638-6","volume":"48","author":"F Ye","year":"2005","unstructured":"Ye, F., Duvilli\u00e9, B. & Scharfmann, R. Fibroblast growth factors 7 and 10 are expressed in the human embryonic pancreatic mesenchyme and promote the proliferation of embryonic pancreatic epithelial cells. Diabetologia 48, 277\u2013281 (2005).","journal-title":"Diabetologia"},{"key":"2098_CR48","first-page":"1409","volume":"122","author":"U Ahlgren","year":"1996","unstructured":"Ahlgren, U., Jonsson, J. & Edlund, H. The morphogenesis of the pancreatic mesenchyme is uncoupled from that of the pancreatic epithelium in IPF1\/PDX1-deficient mice. Dev. Camb. Engl. 122, 1409\u20131416 (1996).","journal-title":"Dev. Camb. Engl."},{"key":"2098_CR49","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.cell.2009.08.049","volume":"139","author":"G Kesavan","year":"2009","unstructured":"Kesavan, G. et al. Cdc42-mediated tubulogenesis controls cell specification. Cell 139, 791\u2013801 (2009).","journal-title":"Cell"},{"key":"2098_CR50","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.devcel.2010.02.005","volume":"18","author":"S Puri","year":"2010","unstructured":"Puri, S. & Hebrok, M. Cellular plasticity within the pancreas-lessons learned from development. Dev. Cell 18, 342\u2013356 (2010).","journal-title":"Dev. Cell"},{"key":"2098_CR51","first-page":"3567","volume":"136","author":"R Desgraz","year":"2009","unstructured":"Desgraz, R. & Herrera, P. L. Pancreatic neurogenin 3-expressing cells are unipotent islet precursors. Dev. Camb. Engl. 136, 3567\u20133574 (2009).","journal-title":"Dev. Camb. Engl."},{"key":"2098_CR52","first-page":"2447","volume":"129","author":"G Gu","year":"2002","unstructured":"Gu, G., Dubauskaite, J. & Melton, D. A. Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors. Dev. Camb. Engl. 129, 2447\u20132457 (2002).","journal-title":"Dev. Camb. Engl."},{"key":"2098_CR53","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1073\/pnas.97.4.1607","volume":"97","author":"G Gradwohl","year":"2000","unstructured":"Gradwohl, G., Dierich, A., LeMeur, M. & Guillemot, F. neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas. Proc. Natl Acad. Sci. USA 97, 1607\u20131611 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2098_CR54","doi-asserted-by":"publisher","first-page":"a012401","DOI":"10.1101\/cshperspect.a012401","volume":"4","author":"CM Benitez","year":"2012","unstructured":"Benitez, C. M., Goodyer, W. R. & Kim, S. K. Deconstructing pancreas developmental biology. Cold Spring Harb. Perspect. Biol. 4, a012401 (2012).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"2098_CR55","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S1534-5807(03)00035-2","volume":"4","author":"M-K Chiang","year":"2003","unstructured":"Chiang, M.-K. & Melton, D. A. Single-cell transcript analysis of pancreas development. Dev. Cell 4, 383\u2013393 (2003).","journal-title":"Dev. Cell"},{"key":"2098_CR56","first-page":"1031","volume":"118","author":"G Teitelman","year":"1993","unstructured":"Teitelman, G., Alpert, S., Polak, J. M., Martinez, A. & Hanahan, D. Precursor cells of mouse endocrine pancreas coexpress insulin, glucagon and the neuronal proteins tyrosine hydroxylase and neuropeptide Y, but not pancreatic polypeptide. Dev. Camb. Engl. 118, 1031\u20131039 (1993).","journal-title":"Dev. Camb. Engl."},{"key":"2098_CR57","doi-asserted-by":"publisher","first-page":"163","DOI":"10.2337\/diabetes.49.2.163","volume":"49","author":"J Jensen","year":"2000","unstructured":"Jensen, J. et al. Independent development of pancreatic alpha- and beta-cells from neurogenin3-expressing precursors: a role for the notch pathway in repression of premature differentiation. Diabetes 49, 163\u2013176 (2000).","journal-title":"Diabetes"},{"key":"2098_CR58","first-page":"2317","volume":"127","author":"PL Herrera","year":"2000","unstructured":"Herrera, P. L. Adult insulin- and glucagon-producing cells differentiate from two independent cell lineages. Dev. Camb. Engl. 127, 2317\u20132322 (2000).","journal-title":"Dev. Camb. Engl."},{"key":"2098_CR59","doi-asserted-by":"publisher","first-page":"12999","DOI":"10.1073\/pnas.91.26.12999","volume":"91","author":"PL Herrera","year":"1994","unstructured":"Herrera, P. L. et al. Ablation of islet endocrine cells by targeted expression of hormone-promoter-driven toxigenes. Proc. Natl Acad. Sci. USA 91, 12999\u201313003 (1994).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2098_CR60","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.humpath.2013.10.008","volume":"45","author":"S Shroff","year":"2014","unstructured":"Shroff, S. et al. SOX9: a useful marker for pancreatic ductal lineage of pancreatic neoplasms. Hum. Pathol. 45, 456\u2013463 (2014).","journal-title":"Hum. Pathol."},{"key":"2098_CR61","doi-asserted-by":"publisher","first-page":"10500","DOI":"10.1073\/pnas.0704054104","volume":"104","author":"FC Lynn","year":"2007","unstructured":"Lynn, F. C. et al. Sox9 coordinates a transcriptional network in pancreatic progenitor cells. Proc. Natl Acad. Sci. USA 104, 10500\u201310505 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2098_CR62","first-page":"2488","volume":"139","author":"HP Shih","year":"2012","unstructured":"Shih, H. P. et al. A Notch-dependent molecular circuitry initiates pancreatic endocrine and ductal cell differentiation. Dev. Camb. Engl. 139, 2488\u20132499 (2012).","journal-title":"Dev. Camb. Engl."},{"key":"2098_CR63","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1242\/dev.120063","volume":"142","author":"RE Jennings","year":"2015","unstructured":"Jennings, R. E., Berry, A. A., Strutt, J. P., Gerrard, D. T. & Hanley, N. A. Human pancreas development. Development 142, 3126\u20133137 (2015).","journal-title":"Development"},{"key":"2098_CR64","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0925-4773(02)00145-4","volume":"116","author":"K Piper","year":"2002","unstructured":"Piper, K. et al. Novel SOX9 expression during human pancreas development correlates to abnormalities in Campomelic dysplasia. Mech. Dev. 116, 223\u2013226 (2002).","journal-title":"Mech. Dev."},{"key":"2098_CR65","doi-asserted-by":"publisher","first-page":"3514","DOI":"10.2337\/db12-1479","volume":"62","author":"RE Jennings","year":"2013","unstructured":"Jennings, R. E. et al. Development of the human pancreas from foregut to endocrine commitment. Diabetes 62, 3514\u20133522 (2013).","journal-title":"Diabetes"},{"key":"2098_CR66","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.stem.2017.01.001","volume":"20","author":"Z-D Shi","year":"2017","unstructured":"Shi, Z.-D. et al. Genome editing in hPSCs reveals GATA6 haploinsufficiency and a genetic interaction with GATA4 in human pancreatic development. Cell Stem Cell 20, 675\u2013688.e6 (2017).","journal-title":"Cell Stem Cell"},{"key":"2098_CR67","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/371606a0","volume":"371","author":"J Jonsson","year":"1994","unstructured":"Jonsson, J., Carlsson, L., Edlund, T. & Edlund, H. Insulin-promoter-factor 1 is required for pancreas development in mice. Nature 371, 606\u2013609 (1994).","journal-title":"Nature"},{"key":"2098_CR68","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/ng0197-106","volume":"15","author":"DA Stoffers","year":"1997","unstructured":"Stoffers, D. A., Zinkin, N. T., Stanojevic, V., Clarke, W. L. & Habener, J. F. Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence. Nat. Genet. 15, 106\u2013110 (1997).","journal-title":"Nat. Genet."},{"key":"2098_CR69","doi-asserted-by":"publisher","first-page":"733","DOI":"10.2337\/db09-1284","volume":"59","author":"M Nicolino","year":"2010","unstructured":"Nicolino, M. et al. A novel hypomorphic PDX1 mutation responsible for permanent neonatal diabetes with subclinical exocrine deficiency. Diabetes 59, 733\u2013740 (2010).","journal-title":"Diabetes"},{"key":"2098_CR70","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.stem.2016.03.015","volume":"18","author":"Z Zhu","year":"2016","unstructured":"Zhu, Z. et al. Genome editing of lineage determinants in human pluripotent stem cells reveals mechanisms of pancreatic development and diabetes. Cell Stem Cell 18, 755\u2013768 (2016).","journal-title":"Cell Stem Cell"},{"key":"2098_CR71","doi-asserted-by":"publisher","first-page":"E707","DOI":"10.1152\/ajpendo.00252.2004","volume":"288","author":"M Brissova","year":"2005","unstructured":"Brissova, M. et al. Reduced PDX-1 expression impairs islet response to insulin resistance and worsens glucose homeostasis. Am. J. Physiol. Endocrinol. Metab. 288, E707\u2013E714 (2005).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"2098_CR72","doi-asserted-by":"publisher","first-page":"19575","DOI":"10.1073\/pnas.0604208103","volume":"103","author":"JD Johnson","year":"2006","unstructured":"Johnson, J. D. et al. Insulin protects islets from apoptosis via Pdx1 and specific changes in the human islet proteome. Proc. Natl Acad. Sci. USA 103, 19575\u201319580 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2098_CR73","doi-asserted-by":"publisher","first-page":"e954436","DOI":"10.4161\/19382014.2014.954436","volume":"6","author":"RJ Salisbury","year":"2014","unstructured":"Salisbury, R. J. et al. The window period of NEUROGENIN3 during human gestation. Islets 6, e954436 (2014).","journal-title":"Islets"},{"key":"2098_CR74","doi-asserted-by":"publisher","first-page":"3270","DOI":"10.1002\/dvdy.21740","volume":"237","author":"A Villasenor","year":"2008","unstructured":"Villasenor, A., Chong, D. C. & Cleaver, O. Biphasic Ngn3 expression in the developing pancreas. Dev. Dyn. 237, 3270\u20133279 (2008).","journal-title":"Dev. Dyn."},{"key":"2098_CR75","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.127657","volume":"5","author":"RS Solorzano-Vargas","year":"2020","unstructured":"Solorzano-Vargas, R. S. et al. Null mutations of NEUROG3 are associated with delayed-onset diabetes mellitus. JCI Insight 5, e127657 (2020).","journal-title":"JCI Insight"},{"key":"2098_CR76","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1056\/NEJMoa054288","volume":"355","author":"J Wang","year":"2006","unstructured":"Wang, J. et al. Mutant neurogenin-3 in congenital malabsorptive diarrhea. N. Engl. J. Med. 355, 270\u2013280 (2006).","journal-title":"N. Engl. J. Med."},{"key":"2098_CR77","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.2337\/db10-1008","volume":"60","author":"O Rubio-Cabezas","year":"2011","unstructured":"Rubio-Cabezas, O. et al. Permanent neonatal diabetes and enteric anendocrinosis associated with biallelic mutations in NEUROG3. Diabetes 60, 1349\u20131353 (2011).","journal-title":"Diabetes"},{"key":"2098_CR78","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.2337\/db14-1412","volume":"64","author":"PS McGrath","year":"2015","unstructured":"McGrath, P. S., Watson, C. L., Ingram, C., Helmrath, M. A. & Wells, J. M. The basic helix-loop-helix transcription factor NEUROG3 is required for development of the human endocrine pancreas. Diabetes 64, 2497\u20132505 (2015).","journal-title":"Diabetes"},{"key":"2098_CR79","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/ng.2897","volume":"46","author":"DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium.","year":"2014","unstructured":"DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium. et al. Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat. Genet. 46, 234\u2013244 (2014).","journal-title":"Nat. Genet."},{"key":"2098_CR80","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1242\/dev.090159","volume":"140","author":"FC Pan","year":"2013","unstructured":"Pan, F. C. et al. Spatiotemporal patterns of multipotentiality in Ptf1a -expressing cells during pancreas organogenesis and injury-induced facultative restoration. Development 140, 751\u2013764 (2013).","journal-title":"Development"},{"key":"2098_CR81","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1172\/JCI29988","volume":"117","author":"BM Desai","year":"2007","unstructured":"Desai, B. M. et al. Preexisting pancreatic acinar cells contribute to acinar cell, but not islet beta cell, regeneration. J. Clin. Invest. 117, 971\u2013977 (2007).","journal-title":"J. Clin. Invest."},{"key":"2098_CR82","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nature02520","volume":"429","author":"Y Dor","year":"2004","unstructured":"Dor, Y., Brown, J., Martinez, O. I. & Melton, D. A. Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 429, 41\u201346 (2004).","journal-title":"Nature"},{"key":"2098_CR83","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.devcel.2007.04.011","volume":"12","author":"M Teta","year":"2007","unstructured":"Teta, M., Rankin, M. M., Long, S. Y., Stein, G. M. & Kushner, J. A. Growth and regeneration of adult beta cells does not involve specialized progenitors. Dev. Cell 12, 817\u2013826 (2007).","journal-title":"Dev. Cell"},{"key":"2098_CR84","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1471-213X-10-38","volume":"10","author":"D Kopinke","year":"2010","unstructured":"Kopinke, D. & Murtaugh, L. C. Exocrine-to-endocrine differentiation is detectable only prior to birth in the uninjured mouse pancreas. BMC Dev. Biol. 10, 38 (2010).","journal-title":"BMC Dev. Biol."},{"key":"2098_CR85","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.devcel.2009.11.003","volume":"17","author":"M Solar","year":"2009","unstructured":"Solar, M. et al. Pancreatic exocrine duct cells give rise to insulin-producing \u03b2 cells during embryogenesis but not after birth. Dev. Cell 17, 849\u2013860 (2009).","journal-title":"Dev. Cell"},{"key":"2098_CR86","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00125-004-1606-1","volume":"48","author":"L Baeyens","year":"2005","unstructured":"Baeyens, L. et al. In vitro generation of insulin-producing beta cells from adult exocrine pancreatic cells. Diabetologia 48, 49\u201357 (2005).","journal-title":"Diabetologia"},{"key":"2098_CR87","doi-asserted-by":"publisher","first-page":"15116","DOI":"10.1073\/pnas.0507567102","volume":"102","author":"K Minami","year":"2005","unstructured":"Minami, K. et al. Lineage tracing and characterization of insulin-secreting cells generated from adult pancreatic acinar cells. Proc. Natl Acad. Sci. USA 102, 15116\u201315121 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2098_CR88","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.2337\/diabetes.53.11.2824","volume":"53","author":"K-H Yew","year":"2004","unstructured":"Yew, K.-H. et al. Interplay of glucagon-like peptide-1 and transforming growth factor-beta signaling in insulin-positive differentiation of AR42J cells. Diabetes 53, 2824\u20132835 (2004).","journal-title":"Diabetes"},{"key":"2098_CR89","doi-asserted-by":"publisher","first-page":"32209","DOI":"10.1074\/jbc.M505465200","volume":"280","author":"K-H Yew","year":"2005","unstructured":"Yew, K.-H. et al. Cross-talk between bone morphogenetic protein and transforming growth factor-beta signaling is essential for exendin-4-induced insulin-positive differentiation of AR42J cells. J. Biol. Chem. 280, 32209\u201332217 (2005).","journal-title":"J. Biol. Chem."},{"key":"2098_CR90","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.2337\/diabetes.48.12.2358","volume":"48","author":"J Zhou","year":"1999","unstructured":"Zhou, J., Wang, X., Pineyro, M. A. & Egan, J. M. Glucagon-like peptide 1 and exendin-4 convert pancreatic AR42J cells into glucagon- and insulin-producing cells. Diabetes 48, 2358\u20132366 (1999).","journal-title":"Diabetes"},{"key":"2098_CR91","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.01846","volume":"3","author":"W Li","year":"2014","unstructured":"Li, W. et al. In vivo reprogramming of pancreatic acinar cells to three islet endocrine subtypes. eLife 3, e01846 (2014).","journal-title":"eLife"},{"key":"2098_CR92","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/nature07314","volume":"455","author":"Q Zhou","year":"2008","unstructured":"Zhou, Q., Brown, J., Kanarek, A., Rajagopal, J. & Melton, D. A. In vivo reprogramming of adult pancreatic exocrine cells to \u03b2-cells. Nature 455, 627\u2013632 (2008).","journal-title":"Nature"},{"key":"2098_CR93","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1016\/j.celrep.2016.10.068","volume":"17","author":"HW Clayton","year":"2016","unstructured":"Clayton, H. W. et al. Pancreatic inflammation redirects acinar to \u03b2 cell reprogramming. Cell Rep. 17, 2028\u20132041 (2016).","journal-title":"Cell Rep."},{"key":"2098_CR94","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.celrep.2014.02.013","volume":"6","author":"Y-J Chen","year":"2014","unstructured":"Chen, Y.-J. et al. De novo formation of insulin-producing \u2018neo-\u03b2 cell islets\u2019 from intestinal crypts. Cell Rep. 6, 1046\u20131058 (2014).","journal-title":"Cell Rep."},{"key":"2098_CR95","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.mce.2012.02.024","volume":"358","author":"MJ Lima","year":"2012","unstructured":"Lima, M. J., Docherty, H. M., Chen, Y. & Docherty, K. Efficient differentiation of AR42J cells towards insulin-producing cells using pancreatic transcription factors in combination with growth factors. Mol. Cell. Endocrinol. 358, 69\u201380 (2012).","journal-title":"Mol. Cell. Endocrinol."},{"key":"2098_CR96","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1002\/jcp.22982","volume":"227","author":"T Zhang","year":"2012","unstructured":"Zhang, T., Saunee, N. A., Breslin, M. B., Song, K. & Lan, M. S. Functional role of an islet transcription factor, INSM1\/IA-1, on pancreatic acinar cell trans-differentiation. J. Cell. Physiol. 227, 2470\u20132479 (2012).","journal-title":"J. Cell. Physiol."},{"key":"2098_CR97","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1007\/s00125-011-2434-8","volume":"55","author":"JK Mfopou","year":"2012","unstructured":"Mfopou, J. K., Baeyens, L. & Bouwens, L. Hedgehog signals inhibit postnatal beta cell neogenesis from adult rat exocrine pancreas in vitro. Diabetologia 55, 1024\u20131034 (2012).","journal-title":"Diabetologia"},{"key":"2098_CR98","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1053\/j.gastro.2009.01.047","volume":"136","author":"L Baeyens","year":"2009","unstructured":"Baeyens, L. et al. Notch signaling as gatekeeper of rat acinar-to-\u03b2-cell conversion in vitro. Gastroenterology 136, 1750\u20131760.e13 (2009).","journal-title":"Gastroenterology"},{"key":"2098_CR99","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.cell.2007.12.015","volume":"132","author":"X Xu","year":"2008","unstructured":"Xu, X. et al. Beta cells can be generated from endogenous progenitors in injured adult mouse pancreas. Cell 132, 197\u2013207 (2008).","journal-title":"Cell"},{"key":"2098_CR100","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/j.1399-543X.2004.00075.x","volume":"5","author":"S Bonner-Weir","year":"2004","unstructured":"Bonner-Weir, S. et al. The pancreatic ductal epithelium serves as a potential pool of progenitor cells. Pediatr. Diabetes 5 (Suppl. 2), 16\u201322 (2004).","journal-title":"Pediatr. Diabetes"},{"key":"2098_CR101","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1053\/j.gastro.2011.07.003","volume":"141","author":"A Criscimanna","year":"2011","unstructured":"Criscimanna, A. et al. Duct cells contribute to regeneration of endocrine and acinar cells following pancreatic damage in adult mice. Gastroenterology 141, 1451\u20131462.e6 (2011).","journal-title":"Gastroenterology"},{"key":"2098_CR102","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.bbrc.2006.09.154","volume":"350","author":"Y Tokui","year":"2006","unstructured":"Tokui, Y. et al. Neogenesis and proliferation of \u03b2-cells induced by human betacellulin gene transduction via retrograde pancreatic duct injection of an adenovirus vector. Biochem. Biophys. Res. Commun. 350, 987\u2013993 (2006).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2098_CR103","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1042\/BST0360353","volume":"36","author":"S Bonner-Weir","year":"2008","unstructured":"Bonner-Weir, S. et al. Transdifferentiation of pancreatic ductal cells to endocrine \u03b2-cells. Biochem. Soc. Trans. 36, 353\u2013356 (2008).","journal-title":"Biochem. Soc. Trans."},{"key":"2098_CR104","doi-asserted-by":"publisher","first-page":"13753","DOI":"10.1074\/jbc.M710034200","volume":"283","author":"K Minami","year":"2008","unstructured":"Minami, K., Okano, H., Okumachi, A. & Seino, S. Role of cadherin-mediated cell-cell adhesion in pancreatic exocrine-to-endocrine transdifferentiation. J. Biol. Chem. 283, 13753\u201313761 (2008).","journal-title":"J. Biol. Chem."},{"key":"2098_CR105","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s11626-021-00580-8","volume":"57","author":"M Vakilian","year":"2021","unstructured":"Vakilian, M., Hmadcha, A., Soria, B. & Ghaedi, K. A new shortened protocol to obtain islet-like cells from hESC-derived ductal cells. In Vitro Cell. Dev. Biol. Anim. 57, 587\u2013597 (2021).","journal-title":"In Vitro Cell. Dev. Biol. Anim."},{"key":"2098_CR106","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04160-2","volume":"12","author":"X Zhang","year":"2021","unstructured":"Zhang, X. et al. Inhibition of Notch activity promotes pancreatic cytokeratin 5-positive cell differentiation to beta cells and improves glucose homeostasis following acute pancreatitis. Cell Death Dis. 12, 867 (2021).","journal-title":"Cell Death Dis."},{"key":"2098_CR107","doi-asserted-by":"publisher","first-page":"e0133862","DOI":"10.1371\/journal.pone.0133862","volume":"10","author":"DL Gomez","year":"2015","unstructured":"Gomez, D. L. et al. Neurogenin 3 expressing cells in the human exocrine pancreas have the capacity for endocrine cell fate. PLoS ONE 10, e0133862 (2015).","journal-title":"PLoS ONE"},{"key":"2098_CR108","doi-asserted-by":"publisher","first-page":"e0201536","DOI":"10.1371\/journal.pone.0201536","volume":"13","author":"A Vieira","year":"2018","unstructured":"Vieira, A. et al. Neurog3 misexpression unravels mouse pancreatic ductal cell plasticity. PLoS ONE 13, e0201536 (2018).","journal-title":"PLoS ONE"},{"key":"2098_CR109","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.stem.2014.06.019","volume":"15","author":"R Sancho","year":"2014","unstructured":"Sancho, R., Gruber, R., Gu, G. & Behrens, A. Loss of Fbw7 reprograms adult pancreatic ductal cells into \u03b1, \u03b4, and \u03b2 cells. Cell Stem Cell 15, 139\u2013153 (2014).","journal-title":"Cell Stem Cell"},{"key":"2098_CR110","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/nrgastro.2017.12","volume":"14","author":"P Storz","year":"2017","unstructured":"Storz, P. Acinar cell plasticity and development of pancreatic ductal adenocarcinoma. Nat. Rev. Gastroenterol. Hepatol. 14, 296\u2013304 (2017).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"2098_CR111","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3390\/metabo11040218","volume":"11","author":"N Honzawa","year":"2021","unstructured":"Honzawa, N. & Fujimoto, K. The plasticity of pancreatic \u03b2-cells. Metabolites 11, 218 (2021).","journal-title":"Metabolites"},{"key":"2098_CR112","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.mce.2009.02.016","volume":"304","author":"A Nadal","year":"2009","unstructured":"Nadal, A., Alonso-Magdalena, P., Soriano, S., Quesada, I. & Ropero, A. B. The pancreatic beta-cell as a target of estrogens and xenoestrogens: Implications for blood glucose homeostasis and diabetes. Mol. Cell. Endocrinol. 304, 63\u201368 (2009).","journal-title":"Mol. Cell. Endocrinol."},{"key":"2098_CR113","doi-asserted-by":"publisher","first-page":"807","DOI":"10.3390\/biom13050807","volume":"13","author":"L Baghaie","year":"2023","unstructured":"Baghaie, L., Bunsick, D. A. & Szewczuk, M. R. Insulin receptor signaling in health and disease. Biomolecules 13, 807 (2023).","journal-title":"Biomolecules"},{"key":"2098_CR114","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.3390\/ijms20133314","volume":"20","author":"L Janah","year":"2019","unstructured":"Janah, L. et al. Glucagon receptor signaling and glucagon resistance. Int. J. Mol. Sci. 20, 3314 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"2098_CR115","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2016.6","volume":"48","author":"PV R\u00f6der","year":"2016","unstructured":"R\u00f6der, P. V., Wu, B., Liu, Y. & Han, W. Pancreatic regulation of glucose homeostasis. Exp. Mol. Med. 48, e219 (2016).","journal-title":"Exp. Mol. Med."},{"key":"2098_CR116","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1042\/bj0600556","volume":"60","author":"H Brown","year":"1955","unstructured":"Brown, H., Sanger, F. & Kitai, R. The structure of pig and sheep insulins. Biochem. J. 60, 556\u2013565 (1955).","journal-title":"Biochem. J."},{"key":"2098_CR117","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/0026-0495(77)90099-3","volume":"26","author":"AE Kitabchi","year":"1977","unstructured":"Kitabchi, A. E. Proinsulin and C-peptide: a review. Metabolism 26, 547\u2013587 (1977).","journal-title":"Metabolism"},{"key":"2098_CR118","doi-asserted-by":"publisher","first-page":"5523","DOI":"10.1021\/acs.biochem.5b00805","volume":"54","author":"SA Tatulian","year":"2015","unstructured":"Tatulian, S. A. Structural dynamics of insulin receptor and transmembrane signaling. Biochemistry 54, 5523\u20135532 (2015).","journal-title":"Biochemistry"},{"key":"2098_CR119","first-page":"972","volume":"86","author":"Y Kido","year":"2001","unstructured":"Kido, Y., Nakae, J. & Accili, D. Clinical review 125: the insulin receptor and its cellular targets. J. Clin. Endocrinol. Metab. 86, 972\u2013979 (2001).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2098_CR120","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1210\/er.2008-0047","volume":"30","author":"A Belfiore","year":"2009","unstructured":"Belfiore, A., Frasca, F., Pandini, G., Sciacca, L. & Vigneri, R. Insulin receptor isoforms and insulin receptor\/insulin-like growth factor receptor hybrids in physiology and disease. Endocr. Rev. 30, 586\u2013623 (2009).","journal-title":"Endocr. Rev."},{"key":"2098_CR121","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/298667a0","volume":"298","author":"M Kasuga","year":"1982","unstructured":"Kasuga, M., Zick, Y., Blithe, D. L., Crettaz, M. & Kahn, C. R. Insulin stimulates tyrosine phosphorylation of the insulin receptor in a cell-free system. Nature 298, 667\u2013669 (1982).","journal-title":"Nature"},{"key":"2098_CR122","doi-asserted-by":"publisher","first-page":"10020","DOI":"10.1016\/S0021-9258(17)44600-X","volume":"258","author":"JA Hedo","year":"1983","unstructured":"Hedo, J. A., Kahn, C. R., Hayashi, M., Yamada, K. M. & Kasuga, M. Biosynthesis and glycosylation of the insulin receptor. Evidence for a single polypeptide precursor of the two major subunits. J. Biol. Chem. 258, 10020\u201310026 (1983).","journal-title":"J. Biol. Chem."},{"key":"2098_CR123","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/B978-0-12-571148-7.50015-4","volume":"48","author":"CR Kahn","year":"1993","unstructured":"Kahn, C. R. et al. The insulin receptor and its substrate: molecular determinants of early events in insulin action. Recent Prog. Horm. Res. 48, 291\u2013339 (1993).","journal-title":"Recent Prog. Horm. Res."},{"key":"2098_CR124","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/nrm.2017.89","volume":"19","author":"RA Haeusler","year":"2018","unstructured":"Haeusler, R. A., McGraw, T. E. & Accili, D. Biochemical and cellular properties of insulin receptor signalling. Nat. Rev. Mol. Cell Biol. 19, 31\u201344 (2018).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2098_CR125","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00592-010-0227-z","volume":"48","author":"M Annunziata","year":"2011","unstructured":"Annunziata, M., Granata, R. & Ghigo, E. The IGF system. Acta Diabetol. 48, 1\u20139 (2011).","journal-title":"Acta Diabetol."},{"key":"2098_CR126","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/1359-6101(96)00002-0","volume":"7","author":"CH Heldin","year":"1996","unstructured":"Heldin, C. H. & Ostman, A. Ligand-induced dimerization of growth factor receptors: variations on the theme. Cytokine Growth Factor Rev. 7, 3\u201310 (1996).","journal-title":"Cytokine Growth Factor Rev."},{"key":"2098_CR127","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1242\/jcs.1985.Supplement_3.5","volume":"3","author":"SP Nissley","year":"1985","unstructured":"Nissley, S. P., Haskell, J. F., Sasaki, N., De Vroede, M. A. & Rechler, M. M. Insulin-like growth factor receptors. J. Cell Sci. Suppl. 3, 39\u201351 (1985).","journal-title":"J. Cell Sci. Suppl."},{"key":"2098_CR128","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.tibs.2009.07.003","volume":"34","author":"J Brown","year":"2009","unstructured":"Brown, J., Jones, E. Y. & Forbes, B. E. Keeping IGF-II under control: lessons from the IGF-II-IGF2R crystal structure. Trends Biochem. Sci. 34, 612\u2013619 (2009).","journal-title":"Trends Biochem. Sci."},{"key":"2098_CR129","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1146\/annurev.physiol.70.113006.100533","volume":"70","author":"A Taguchi","year":"2008","unstructured":"Taguchi, A. & White, M. F. Insulin-like signaling, nutrient homeostasis, and life span. Annu. Rev. Physiol. 70, 191\u2013212 (2008).","journal-title":"Annu. Rev. Physiol."},{"key":"2098_CR130","first-page":"179","volume":"41","author":"JF Bak","year":"1994","unstructured":"Bak, J. F. Insulin receptor function and glycogen synthase activity in human skeletal muscle. Physiology and pathophysiology. Dan. Med. Bull. 41, 179\u2013192 (1994).","journal-title":"Dan. Med. Bull."},{"key":"2098_CR131","doi-asserted-by":"publisher","first-page":"937","DOI":"10.2337\/diabetes.50.5.937","volume":"50","author":"PA Lochhead","year":"2001","unstructured":"Lochhead, P. A., Coghlan, M., Rice, S. Q. & Sutherland, C. Inhibition of GSK-3 selectively reduces glucose-6-phosphatase and phosphatase and phosphoenolypyruvate carboxykinase gene expression. Diabetes 50, 937\u2013946 (2001).","journal-title":"Diabetes"},{"key":"2098_CR132","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nrm3351","volume":"13","author":"D Leto","year":"2012","unstructured":"Leto, D. & Saltiel, A. R. Regulation of glucose transport by insulin: traffic control of GLUT4. Nat. Rev. Mol. Cell Biol. 13, 383\u2013396 (2012).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2098_CR133","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1083\/jcb.129.3.641","volume":"129","author":"PM Haney","year":"1995","unstructured":"Haney, P. M., Levy, M. A., Strube, M. S. & Mueckler, M. Insulin-sensitive targeting of the GLUT4 glucose transporter in L6 myoblasts is conferred by its COOH-terminal cytoplasmic tail. J. Cell Biol. 129, 641\u2013658 (1995).","journal-title":"J. Cell Biol."},{"key":"2098_CR134","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1042\/BST20170479","volume":"46","author":"S Mafakheri","year":"2018","unstructured":"Mafakheri, S., Chadt, A. & Al-Hasani, H. Regulation of RabGAPs involved in insulin action. Biochem. Soc. Trans. 46, 683\u2013690 (2018).","journal-title":"Biochem. Soc. Trans."},{"key":"2098_CR135","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1038\/ncb2629","volume":"14","author":"W Yang","year":"2012","unstructured":"Yang, W. et al. ERK1\/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect. Nat. Cell Biol. 14, 1295\u20131304 (2012).","journal-title":"Nat. Cell Biol."},{"key":"2098_CR136","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3389\/fcell.2018.00079","volume":"6","author":"EK Wiese","year":"2018","unstructured":"Wiese, E. K. & Hitosugi, T. Tyrosine kinase signaling in cancer metabolism: PKM2 paradox in the warburg effect. Front. Cell Dev. Biol. 6, 79 (2018).","journal-title":"Front. Cell Dev. Biol."},{"key":"2098_CR137","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/cr.2015.133","volume":"26","author":"Y Yin","year":"2016","unstructured":"Yin, Y. et al. mTORC2 promotes type I insulin-like growth factor receptor and insulin receptor activation through the tyrosine kinase activity of mTOR. Cell Res. 26, 46\u201365 (2016).","journal-title":"Cell Res."},{"key":"2098_CR138","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13045-019-0754-1","volume":"12","author":"H Hua","year":"2019","unstructured":"Hua, H. et al. Targeting mTOR for cancer therapy. J. Hematol. Oncol. J. Hematol. Oncol. 12, 71 (2019).","journal-title":"J. Hematol. Oncol. J. Hematol. Oncol."},{"key":"2098_CR139","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1006\/excr.1999.4683","volume":"253","author":"A Dufner","year":"1999","unstructured":"Dufner, A. & Thomas, G. Ribosomal S6 kinase signaling and the control of translation. Exp. Cell Res. 253, 100\u2013109 (1999).","journal-title":"Exp. Cell Res."},{"key":"2098_CR140","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S1097-2765(02)00568-3","volume":"10","author":"BD Manning","year":"2002","unstructured":"Manning, B. D., Tee, A. R., Logsdon, M. N., Blenis, J. & Cantley, L. C. Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase\/akt pathway. Mol. Cell 10, 151\u2013162 (2002).","journal-title":"Mol. Cell"},{"key":"2098_CR141","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.3390\/cells9122648","volume":"9","author":"FI Montalto","year":"2020","unstructured":"Montalto, F. I. & De Amicis, F. Cyclin D1 in cancer: a molecular connection for cell cycle control, adhesion and invasion in tumor and stroma. Cells 9, 2648 (2020).","journal-title":"Cells"},{"key":"2098_CR142","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07644-6","volume":"9","author":"A Kazi","year":"2018","unstructured":"Kazi, A. et al. GSK3 suppression upregulates \u03b2-catenin and c-Myc to abrogate KRas-dependent tumors. Nat. Commun. 9, 5154 (2018).","journal-title":"Nat. Commun."},{"key":"2098_CR143","doi-asserted-by":"publisher","first-page":"6139","DOI":"10.1128\/MCB.23.17.6139-6149.2003","volume":"23","author":"A Radu","year":"2003","unstructured":"Radu, A., Neubauer, V., Akagi, T., Hanafusa, H. & Georgescu, M.-M. PTEN induces cell cycle arrest by decreasing the level and nuclear localization of cyclin D1. Mol. Cell. Biol. 23, 6139\u20136149 (2003).","journal-title":"Mol. Cell. Biol."},{"key":"2098_CR144","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1017\/S1462399408000744","volume":"10","author":"AM Abukhdeir","year":"2008","unstructured":"Abukhdeir, A. M. & Park, B. H. P21 and p27: roles in carcinogenesis and drug resistance. Expert Rev. Mol. Med. 10, e19 (2008).","journal-title":"Expert Rev. Mol. Med."},{"key":"2098_CR145","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1042\/BST20120092","volume":"40","author":"M-K Yoon","year":"2012","unstructured":"Yoon, M.-K., Mitrea, D. M., Ou, L. & Kriwacki, R. W. Cell cycle regulation by the intrinsically disordered proteins p21 and p27. Biochem. Soc. Trans. 40, 981\u2013988 (2012).","journal-title":"Biochem. Soc. Trans."},{"key":"2098_CR146","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.3389\/fphar.2019.01176","volume":"10","author":"Y Chen","year":"2019","unstructured":"Chen, Y. et al. Akt regulated phosphorylation of GSK-3\u03b2\/cyclin D1, p21 and p27 contributes to cell proliferation through cell cycle progression from G1 to S\/G2M phase in low-dose arsenite exposed HaCat cells. Front. Pharmacol. 10, 1176 (2019).","journal-title":"Front. Pharmacol."},{"key":"2098_CR147","first-page":"3079","volume":"140","author":"S Lim","year":"2013","unstructured":"Lim, S. & Kaldis, P. Cdks, cyclins and CKIs: roles beyond cell cycle regulation. Dev. Camb. Engl. 140, 3079\u20133093 (2013).","journal-title":"Dev. Camb. Engl."},{"key":"2098_CR148","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/0959-437X(94)90097-3","volume":"4","author":"R Treisman","year":"1994","unstructured":"Treisman, R. Ternary complex factors: growth factor regulated transcriptional activators. Curr. Opin. Genet. Dev. 4, 96\u2013101 (1994).","journal-title":"Curr. Opin. Genet. Dev."},{"key":"2098_CR149","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.bbagrm.2013.05.004","volume":"1829","author":"A Kasza","year":"2013","unstructured":"Kasza, A. Signal-dependent Elk-1 target genes involved in transcript processing and cell migration. Biochim. Biophys. Acta 1829, 1026\u20131033 (2013).","journal-title":"Biochim. Biophys. Acta"},{"key":"2098_CR150","doi-asserted-by":"publisher","first-page":"11242","DOI":"10.1073\/pnas.93.20.11242","volume":"93","author":"DM Cohen","year":"1996","unstructured":"Cohen, D. M. Urea-inducible Egr-1 transcription in renal inner medullary collecting duct (mIMCD3) cells is mediated by extracellular signal-regulated kinase activation. Proc. Natl Acad. Sci. USA 93, 11242\u201311247 (1996).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2098_CR151","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/354531a0","volume":"354","author":"RA Hipskind","year":"1991","unstructured":"Hipskind, R. A., Rao, V. N., Mueller, C. G., Reddy, E. S. & Nordheim, A. Ets-related protein Elk-1 is homologous to the c-fos regulatory factor p62TCF. Nature 354, 531\u2013534 (1991).","journal-title":"Nature"},{"key":"2098_CR152","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/mrd.1080420414","volume":"42","author":"RJ Davis","year":"1995","unstructured":"Davis, R. J. Transcriptional regulation by MAP kinases. Mol. Reprod. Dev. 42, 459\u2013467 (1995).","journal-title":"Mol. Reprod. Dev."},{"key":"2098_CR153","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/S0955-0674(97)80068-3","volume":"9","author":"M Karin","year":"1997","unstructured":"Karin, M., Liu, Z. G. & Zandi, E. AP-1 function and regulation. Curr. Opin. Cell Biol. 9, 240\u2013246 (1997).","journal-title":"Curr. Opin. Cell Biol."},{"key":"2098_CR154","first-page":"685","volume":"12","author":"DA Liebermann","year":"1998","unstructured":"Liebermann, D. A., Gregory, B. & Hoffman, B. AP-1 (Fos\/Jun) transcription factors in hematopoietic differentiation and apoptosis. Int. J. Oncol. 12, 685\u2013700 (1998).","journal-title":"Int. J. Oncol."},{"key":"2098_CR155","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13792","volume":"22","author":"EO Karakaslar","year":"2023","unstructured":"Karakaslar, E. O. et al. Transcriptional activation of Jun and Fos members of the AP-1 complex is a conserved signature of immune aging that contributes to inflammaging. Aging Cell 22, e13792 (2023).","journal-title":"Aging Cell"},{"key":"2098_CR156","first-page":"129","volume":"1072","author":"P Angel","year":"1991","unstructured":"Angel, P. & Karin, M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta 1072, 129\u2013157 (1991).","journal-title":"Biochim. Biophys. Acta"},{"key":"2098_CR157","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S0092-8674(00)80405-5","volume":"91","author":"SR Datta","year":"1997","unstructured":"Datta, S. R. et al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91, 231\u2013241 (1997).","journal-title":"Cell"},{"key":"2098_CR158","first-page":"107","volume":"200","author":"LH Boise","year":"1995","unstructured":"Boise, L. H., Gottschalk, A. R., Quint\u00e1ns, J. & Thompson, C. B. Bcl-2 and Bcl-2-related proteins in apoptosis regulation. Curr. Top. Microbiol. Immunol. 200, 107\u2013121 (1995).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"2098_CR159","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1007\/BF01920110","volume":"52","author":"TJ McDonnell","year":"1996","unstructured":"McDonnell, T. J., Beham, A., Sarkiss, M., Andersen, M. M. & Lo, P. Importance of the Bcl-2 family in cell death regulation. Experientia 52, 1008\u20131017 (1996).","journal-title":"Experientia"},{"key":"2098_CR160","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.cell.2007.09.016","volume":"131","author":"G Tuteja","year":"2007","unstructured":"Tuteja, G. & Kaestner, K. H. Forkhead transcription factors II. Cell 131, 192 (2007).","journal-title":"Cell"},{"key":"2098_CR161","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s10555-020-09883-w","volume":"39","author":"Y Jiramongkol","year":"2020","unstructured":"Jiramongkol, Y. & Lam, E. W.-F. FOXO transcription factor family in cancer and metastasis. Cancer Metastasis Rev. 39, 681\u2013709 (2020).","journal-title":"Cancer Metastasis Rev."},{"key":"2098_CR162","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.bbamcr.2011.06.002","volume":"1813","author":"G Tzivion","year":"2011","unstructured":"Tzivion, G., Dobson, M. & Ramakrishnan, G. FoxO transcription factors; regulation by AKT and 14-3-3 proteins. Biochim. Biophys. Acta 1813, 1938\u20131945 (2011).","journal-title":"Biochim. Biophys. Acta"},{"key":"2098_CR163","doi-asserted-by":"publisher","first-page":"189083","DOI":"10.1016\/j.bbcan.2024.189083","volume":"1879","author":"X Guo","year":"2024","unstructured":"Guo, X., Peng, K., He, Y. & Xue, L. Mechanistic regulation of FOXO transcription factors in the nucleus. Biochim. Biophys. Acta Rev. Cancer 1879, 189083 (2024).","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"2098_CR164","doi-asserted-by":"publisher","first-page":"a022608","DOI":"10.1101\/cshperspect.a022608","volume":"10","author":"HV Goodson","year":"2018","unstructured":"Goodson, H. V. & Jonasson, E. M. Microtubules and microtubule-associated proteins. Cold Spring Harb. Perspect. Biol. 10, a022608 (2018).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"2098_CR165","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.tcb.2019.07.004","volume":"29","author":"S Bodakuntla","year":"2019","unstructured":"Bodakuntla, S., Jijumon, A. S., Villablanca, C., Gonzalez-Billault, C. & Janke, C. Microtubule-associated proteins: structuring the cytoskeleton. Trends Cell Biol. 29, 804\u2013819 (2019).","journal-title":"Trends Cell Biol."},{"key":"2098_CR166","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1046\/j.1471-4159.1998.70052139.x","volume":"70","author":"GI Welsh","year":"1998","unstructured":"Welsh, G. I., Hall, D. A., Warnes, A., Strange, P. G. & Proud, C. G. Activation of microtubule-associated protein kinase (Erk) and p70 S6 kinase by D2 dopamine receptors. J. Neurochem. 70, 2139\u20132146 (1998).","journal-title":"J. Neurochem."},{"key":"2098_CR167","doi-asserted-by":"publisher","first-page":"8487","DOI":"10.1073\/pnas.89.18.8487","volume":"89","author":"SK Hanks","year":"1992","unstructured":"Hanks, S. K., Calalb, M. B., Harper, M. C. & Patel, S. K. Focal adhesion protein-tyrosine kinase phosphorylated in response to cell attachment to fibronectin. Proc. Natl Acad. Sci. USA 89, 8487\u20138491 (1992).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2098_CR168","doi-asserted-by":"publisher","first-page":"5192","DOI":"10.1073\/pnas.89.11.5192","volume":"89","author":"MD Schaller","year":"1992","unstructured":"Schaller, M. D. et al. pp125FAK a structurally distinctive protein-tyrosine kinase associated with focal adhesions. Proc. Natl Acad. Sci. USA 89, 5192\u20135196 (1992).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2098_CR169","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3390\/biom10020179","volume":"10","author":"P Tapial Mart\u00ednez","year":"2020","unstructured":"Tapial Mart\u00ednez, P., L\u00f3pez Navajas, P. & Lietha, D. FAK structure and regulation by membrane interactions and force in focal adhesions. Biomolecules 10, 179 (2020).","journal-title":"Biomolecules"},{"key":"2098_CR170","doi-asserted-by":"publisher","first-page":"11418","DOI":"10.1074\/jbc.M109.090746","volume":"285","author":"KT Chan","year":"2010","unstructured":"Chan, K. T., Bennin, D. A. & Huttenlocher, A. Regulation of adhesion dynamics by calpain-mediated proteolysis of focal adhesion kinase (FAK). J. Biol. Chem. 285, 11418\u201311426 (2010).","journal-title":"J. Biol. Chem."},{"key":"2098_CR171","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.addr.2010.11.001","volume":"63","author":"X Zhao","year":"2011","unstructured":"Zhao, X. & Guan, J.-L. Focal adhesion kinase and its signaling pathways in cell migration and angiogenesis. Adv. Drug Deliv. Rev. 63, 610\u2013615 (2011).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"2098_CR172","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1083\/jcb.201508080","volume":"212","author":"ER Horton","year":"2016","unstructured":"Horton, E. R. et al. Modulation of FAK and Src adhesion signaling occurs independently of adhesion complex composition. J. Cell Biol. 212, 349\u2013364 (2016).","journal-title":"J. Cell Biol."},{"key":"2098_CR173","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1128\/MCB.16.3.1212","volume":"16","author":"TL Fisher","year":"1996","unstructured":"Fisher, T. L. & Blenis, J. Evidence for two catalytically active kinase domains in pp90rsk. Mol. Cell. Biol. 16, 1212\u20131219 (1996).","journal-title":"Mol. Cell. Biol."},{"key":"2098_CR174","first-page":"8330","volume":"63","author":"KM Eisenmann","year":"2003","unstructured":"Eisenmann, K. M., VanBrocklin, M. W., Staffend, N. A., Kitchen, S. M. & Koo, H.-M. Mitogen-activated protein kinase pathway-dependent tumor-specific survival signaling in melanoma cells through inactivation of the proapoptotic protein bad. Cancer Res. 63, 8330\u20138337 (2003).","journal-title":"Cancer Res."},{"key":"2098_CR175","doi-asserted-by":"publisher","first-page":"12202","DOI":"10.1073\/pnas.95.21.12202","volume":"95","author":"D De Cesare","year":"1998","unstructured":"De Cesare, D., Jacquot, S., Hanauer, A. & Sassone-Corsi, P. Rsk-2 activity is necessary for epidermal growth factor-induced phosphorylation of CREB protein and transcription of c-fos gene. Proc. Natl Acad. Sci. USA 95, 12202\u201312207 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2098_CR176","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.3390\/ijms21051770","volume":"21","author":"N Rachdaoui","year":"2020","unstructured":"Rachdaoui, N. Insulin: the friend and the foe in the development of type 2 diabetes mellitus. Int. J. Mol. Sci. 21, 1770 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"2098_CR177","doi-asserted-by":"publisher","first-page":"3473","DOI":"10.2337\/db16-0240","volume":"65","author":"K F\u00e6rch","year":"2016","unstructured":"F\u00e6rch, K. et al. Insulin resistance is accompanied by increased fasting glucagon and delayed glucagon suppression in individuals with normal and impaired glucose regulation. Diabetes 65, 3473\u20133481 (2016).","journal-title":"Diabetes"},{"key":"2098_CR178","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.2217\/bmm-2016-0090","volume":"10","author":"NJ Wewer Albrechtsen","year":"2016","unstructured":"Wewer Albrechtsen, N. J., Kuhre, R. E., Pedersen, J., Knop, F. K. & Holst, J. J. The biology of glucagon and the consequences of hyperglucagonemia. Biomark. Med. 10, 1141\u20131151 (2016).","journal-title":"Biomark. Med."},{"key":"2098_CR179","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/jdi.13745","volume":"13","author":"B Thorens","year":"2022","unstructured":"Thorens, B. Neuronal regulation of glucagon secretion and gluconeogenesis. J. Diabetes Investig. 13, 599\u2013607 (2022).","journal-title":"J. Diabetes Investig."},{"key":"2098_CR180","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/j.1463-1326.2011.01453.x","volume":"13","author":"B Thorens","year":"2011","unstructured":"Thorens, B. Brain glucose sensing and neural regulation of insulin and glucagon secretion. Diabetes Obes. Metab. 13 (Suppl. 1), 82\u201388 (2011).","journal-title":"Diabetes Obes. Metab."},{"key":"2098_CR181","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1002\/cphy.c200013","volume":"11","author":"A Zeigerer","year":"2021","unstructured":"Zeigerer, A. et al. Glucagon\u2019s metabolic action in health and disease. Compr. Physiol. 11, 1759\u20131783 (2021).","journal-title":"Compr. Physiol."},{"key":"2098_CR182","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/nrendo.2010.187","volume":"6","author":"KM Habegger","year":"2010","unstructured":"Habegger, K. M. et al. The metabolic actions of glucagon revisited. Nat. Rev. Endocrinol. 6, 689\u2013697 (2010).","journal-title":"Nat. Rev. Endocrinol."},{"key":"2098_CR183","doi-asserted-by":"publisher","first-page":"837664","DOI":"10.3389\/fphar.2022.837664","volume":"13","author":"SL Armour","year":"2022","unstructured":"Armour, S. L., Frueh, A. & Knudsen, J. G. Sodium, glucose and dysregulated glucagon secretion: the potential of sodium glucose transporters. Front. Pharmacol. 13, 837664 (2022).","journal-title":"Front. Pharmacol."},{"key":"2098_CR184","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/dom.13381","volume":"20","author":"JW Hughes","year":"2018","unstructured":"Hughes, J. W., Ustione, A., Lavagnino, Z. & Piston, D. W. Regulation of islet glucagon secretion: beyond calcium. Diabetes Obes. Metab. 20 (Suppl. 2), 127\u2013136 (2018).","journal-title":"Diabetes Obes. Metab."},{"key":"2098_CR185","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s00125-020-05288-0","volume":"64","author":"B Svendsen","year":"2021","unstructured":"Svendsen, B. & Holst, J. J. Paracrine regulation of somatostatin secretion by insulin and glucagon in mouse pancreatic islets. Diabetologia 64, 142\u2013151 (2021).","journal-title":"Diabetologia"},{"key":"2098_CR186","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/dom.12346","volume":"16","author":"B Thorens","year":"2014","unstructured":"Thorens, B. Neural regulation of pancreatic islet cell mass and function. Diabetes Obes. Metab. 16 (Suppl. 1), 87\u201395 (2014).","journal-title":"Diabetes Obes. Metab."},{"key":"2098_CR187","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0079-6603(08)60049-5","volume":"49","author":"CM Fraser","year":"1994","unstructured":"Fraser, C. M., Lee, N. H., Pellegrino, S. M. & Kerlavage, A. R. Molecular properties and regulation of G-protein-coupled receptors. Prog. Nucleic Acid Res. Mol. Biol. 49, 113\u2013156 (1994).","journal-title":"Prog. Nucleic Acid Res. Mol. Biol."},{"key":"2098_CR188","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.tips.2013.11.001","volume":"35","author":"K Hollenstein","year":"2014","unstructured":"Hollenstein, K. et al. Insights into the structure of class B GPCRs. Trends Pharmacol. Sci. 35, 12\u201322 (2014).","journal-title":"Trends Pharmacol. Sci."},{"key":"2098_CR189","first-page":"16","volume":"2016","author":"E Larger","year":"2016","unstructured":"Larger, E. et al. Pancreatic \u03b1-cell hyperplasia and hyperglucagonemia due to a glucagon receptor splice mutation. Endocrinol. Diabetes Metab. Case Rep. 2016, 16\u20130081 (2016).","journal-title":"Endocrinol. Diabetes Metab. Case Rep."},{"key":"2098_CR190","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/00006676-199903000-00006","volume":"18","author":"CN Huang","year":"1999","unstructured":"Huang, C. N. et al. Screening for the Gly40Ser mutation in the glucagon receptor gene among patients with type 2 diabetes or essential hypertension in Taiwan. Pancreas 18, 151\u2013155 (1999).","journal-title":"Pancreas"},{"key":"2098_CR191","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/s41586-023-06467-w","volume":"621","author":"L-H Zhao","year":"2023","unstructured":"Zhao, L.-H. et al. Conserved class B GPCR activation by a biased intracellular agonist. Nature 621, 635\u2013641 (2023).","journal-title":"Nature"},{"key":"2098_CR192","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1083\/jcb.126.3.677","volume":"126","author":"SH Hansen","year":"1994","unstructured":"Hansen, S. H. & Casanova, J. E. Gs alpha stimulates transcytosis and apical secretion in MDCK cells through cAMP and protein kinase A. J. Cell Biol. 126, 677\u2013687 (1994).","journal-title":"J. Cell Biol."},{"key":"2098_CR193","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/j.1463-1326.2011.01454.x","volume":"13","author":"CJ Ramnanan","year":"2011","unstructured":"Ramnanan, C. J., Edgerton, D. S., Kraft, G. & Cherrington, A. D. Physiologic action of glucagon on liver glucose metabolism. Diabetes Obes. Metab. 13 (Suppl. 1), 118\u2013125 (2011).","journal-title":"Diabetes Obes. Metab."},{"key":"2098_CR194","first-page":"285","volume":"5","author":"SJ Beebe","year":"1994","unstructured":"Beebe, S. J. The cAMP-dependent protein kinases and cAMP signal transduction. Semin. Cancer Biol. 5, 285\u2013294 (1994).","journal-title":"Semin. Cancer Biol."},{"key":"2098_CR195","first-page":"2822","volume":"13","author":"BE Wadzinski","year":"1993","unstructured":"Wadzinski, B. E. et al. Nuclear protein phosphatase 2A dephosphorylates protein kinase A-phosphorylated CREB and regulates CREB transcriptional stimulation. Mol. Cell. Biol. 13, 2822\u20132834 (1993).","journal-title":"Mol. Cell. Biol."},{"key":"2098_CR196","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1042\/BJ20040752","volume":"381","author":"MH Rider","year":"2004","unstructured":"Rider, M. H. et al. 6-phosphofructo-2-kinase\/fructose-2,6-bisphosphatase: head-to-head with a bifunctional enzyme that controls glycolysis. Biochem. J. 381, 561\u2013579 (2004).","journal-title":"Biochem. J."},{"key":"2098_CR197","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1042\/BJ20051642","volume":"396","author":"P Portela","year":"2006","unstructured":"Portela, P., Moreno, S. & Rossi, S. Characterization of yeast pyruvate kinase 1 as a protein kinase A substrate, and specificity of the phosphorylation site sequence in the whole protein. Biochem. J. 396, 117\u2013126 (2006).","journal-title":"Biochem. J."},{"key":"2098_CR198","doi-asserted-by":"publisher","first-page":"D618","DOI":"10.2741\/Brushia","volume":"4","author":"RJ Brushia","year":"1999","unstructured":"Brushia, R. J. & Walsh, D. A. Phosphorylase kinase: the complexity of its regulation is reflected in the complexity of its structure. Front. Biosci. J. Virtual Libr. 4, D618\u2013D641 (1999).","journal-title":"Front. Biosci. J. Virtual Libr."},{"key":"2098_CR199","first-page":"183","volume":"13","author":"O Hamberg","year":"1994","unstructured":"Hamberg, O. & Vilstrup, H. Regulation of urea synthesis by glucose and glucagon in normal man. Clin. Nutr. Edinb. Scotl. 13, 183\u2013191 (1994).","journal-title":"Clin. Nutr. Edinb. Scotl."},{"key":"2098_CR200","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1016\/S0021-9258(17)40885-4","volume":"253","author":"PJ Snodgrass","year":"1978","unstructured":"Snodgrass, P. J., Lin, R. C., M\u00fcller, W. A. & Aoki, T. T. Induction of urea cycle enzymes of rat liver by glucagon. J. Biol. Chem. 253, 2748\u20132753 (1978).","journal-title":"J. Biol. Chem."},{"key":"2098_CR201","doi-asserted-by":"publisher","first-page":"e29527","DOI":"10.1371\/journal.pone.0029527","volume":"7","author":"SK Heibel","year":"2012","unstructured":"Heibel, S. K. et al. Transcriptional regulation of N-acetylglutamate synthase. PloS One 7, e29527 (2012).","journal-title":"PloS One"},{"key":"2098_CR202","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/B978-0-12-152825-6.50009-6","volume":"25","author":"MS Kilberg","year":"1985","unstructured":"Kilberg, M. S., Barber, E. F. & Handlogten, M. E. Characteristics and hormonal regulation of amino acid transport system A in isolated rat hepatocytes. Curr. Top. Cell. Regul. 25, 133\u2013163 (1985).","journal-title":"Curr. Top. Cell. Regul."},{"key":"2098_CR203","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/bmb.2005.494033010419","volume":"33","author":"J Boyle","year":"2005","unstructured":"Boyle, J. Lehninger principles of biochemistry (4th ed.): Nelson, D., and Cox, M. Biochem. Mol. Biol. Educ. 33, 74\u201375 (2005).","journal-title":"Biochem. Mol. Biol. Educ."},{"key":"2098_CR204","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/0168-8278(90)90072-Y","volume":"10","author":"H Vilstrup","year":"1990","unstructured":"Vilstrup, H., Hansen, B. A. & Almdal, T. P. Glucagon increases hepatic efficacy for urea synthesis. J. Hepatol. 10, 46\u201350 (1990).","journal-title":"J. Hepatol."},{"key":"2098_CR205","doi-asserted-by":"publisher","first-page":"E93","DOI":"10.1152\/ajpendo.00198.2017","volume":"314","author":"KD Galsgaard","year":"2018","unstructured":"Galsgaard, K. D. et al. Disruption of glucagon receptor signaling causes hyperaminoacidemia exposing a possible liver-alpha-cell axis. Am. J. Physiol. Endocrinol. Metab. 314, E93\u2013E103 (2018).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"2098_CR206","doi-asserted-by":"publisher","first-page":"12","DOI":"10.2337\/diab.41.1.12","volume":"41","author":"TP Almdal","year":"1992","unstructured":"Almdal, T. P., Holst, J. J., Heindorff, H. & Vilstrup, H. Glucagon immunoneutralization in diabetic rats normalizes urea synthesis and decreases nitrogen wasting. Diabetes 41, 12\u201316 (1992).","journal-title":"Diabetes"},{"key":"2098_CR207","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1172\/JCI118782","volume":"98","author":"MR Charlton","year":"1996","unstructured":"Charlton, M. R., Adey, D. B. & Nair, K. S. Evidence for a catabolic role of glucagon during an amino acid load. J. Clin. Invest. 98, 90\u201399 (1996).","journal-title":"J. Clin. Invest."},{"key":"2098_CR208","doi-asserted-by":"publisher","first-page":"549627","DOI":"10.1155\/2013\/549627","volume":"2013","author":"FA Monsalve","year":"2013","unstructured":"Monsalve, F. A., Pyarasani, R. D., Delgado-Lopez, F. & Moore-Carrasco, R. Peroxisome proliferator-activated receptor targets for the treatment of metabolic diseases. Mediat. Inflamm. 2013, 549627 (2013).","journal-title":"Mediat. Inflamm."},{"key":"2098_CR209","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.3390\/ijms21062061","volume":"21","author":"Y Wang","year":"2020","unstructured":"Wang, Y., Nakajima, T., Gonzalez, F. J. & Tanaka, N. PPARs as metabolic regulators in the liver: lessons from liver-specific PPAR-null mice. Int. J. Mol. Sci. 21, 2061 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"2098_CR210","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1210\/er.2018-00064","volume":"39","author":"N Bougarne","year":"2018","unstructured":"Bougarne, N. et al. Molecular actions of PPAR\u03b1 in lipid metabolism and inflammation. Endocr. Rev. 39, 760\u2013802 (2018).","journal-title":"Endocr. Rev."},{"key":"2098_CR211","doi-asserted-by":"publisher","first-page":"108391","DOI":"10.1016\/j.pharmthera.2023.108391","volume":"245","author":"H Chen","year":"2023","unstructured":"Chen, H. et al. PPAR-\u03b3 signaling in nonalcoholic fatty liver disease: pathogenesis and therapeutic targets. Pharmacol. Ther. 245, 108391 (2023).","journal-title":"Pharmacol. Ther."},{"key":"2098_CR212","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.cmet.2008.09.008","volume":"8","author":"C Longuet","year":"2008","unstructured":"Longuet, C. et al. The glucagon receptor is required for the adaptive metabolic response to fasting. Cell Metab. 8, 359\u2013371 (2008).","journal-title":"Cell Metab."},{"key":"2098_CR213","doi-asserted-by":"publisher","first-page":"E1039","DOI":"10.1152\/ajpendo.2000.279.5.E1039","volume":"279","author":"JY Kim","year":"2000","unstructured":"Kim, J. Y., Hickner, R. C., Cortright, R. L., Dohm, G. L. & Houmard, J. A. Lipid oxidation is reduced in obese human skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 279, E1039\u2013E1044 (2000).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"2098_CR214","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1126\/science.179.4068.77","volume":"179","author":"P Brazeau","year":"1973","unstructured":"Brazeau, P. et al. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 179, 77\u201379 (1973).","journal-title":"Science"},{"key":"2098_CR215","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1002\/aja.1001440416","volume":"144","author":"RP Elde","year":"1975","unstructured":"Elde, R. P. & Parsons, J. A. Immunocytochemical localization of somatostatin in cell bodies of the rat hypothalamus. Am. J. Anat. 144, 541\u2013548 (1975).","journal-title":"Am. J. Anat."},{"key":"2098_CR216","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/S0140-6736(74)90869-1","volume":"2","author":"SR Bloom","year":"1974","unstructured":"Bloom, S. R. et al. Inhibition of gastrin and gastric-acid secretion by growth-hormone release-inhibiting hormone. Lancet Lond. Engl. 2, 1106\u20131109 (1974).","journal-title":"Lancet Lond. Engl."},{"key":"2098_CR217","doi-asserted-by":"publisher","first-page":"876","DOI":"10.2337\/diab.23.11.876","volume":"23","author":"JE Gerich","year":"1974","unstructured":"Gerich, J. E. et al. Inhibition of pancreatic glucagon responses to arginine by somatostatin in normal man and in insulin-dependent diabetics. Diabetes 23, 876\u2013880 (1974).","journal-title":"Diabetes"},{"key":"2098_CR218","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1006\/frne.1999.0183","volume":"20","author":"YC Patel","year":"1999","unstructured":"Patel, Y. C. Somatostatin and its receptor family. Front. Neuroendocrinol. 20, 157\u2013198 (1999).","journal-title":"Front. Neuroendocrinol."},{"key":"2098_CR219","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.tem.2009.12.003","volume":"21","author":"A Ben-Shlomo","year":"2010","unstructured":"Ben-Shlomo, A. & Melmed, S. Pituitary somatostatin receptor signaling. Trends Endocrinol. Metab. 21, 123\u2013133 (2010).","journal-title":"Trends Endocrinol. Metab."},{"key":"2098_CR220","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/j.1471-4159.1986.tb12976.x","volume":"46","author":"MF Beal","year":"1986","unstructured":"Beal, M. F., Tran, V. T., Mazurek, M. F., Chattha, G. & Martin, J. B. Somatostatin binding sites in human and monkey brain: localization and characterization. J. Neurochem. 46, 359\u2013365 (1986).","journal-title":"J. Neurochem."},{"key":"2098_CR221","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1210\/endo-110-3-1049","volume":"110","author":"JC Reubi","year":"1982","unstructured":"Reubi, J. C., Rivier, J., Perrin, M., Brown, M. & Vale, W. Specific high affinity binding sites for somatostatin-28 on pancreatic beta-cells: differences with brain somatostatin receptors. Endocrinology 110, 1049\u20131051 (1982).","journal-title":"Endocrinology"},{"key":"2098_CR222","doi-asserted-by":"publisher","first-page":"7690","DOI":"10.1016\/S0021-9258(19)57455-5","volume":"261","author":"CB Srikant","year":"1986","unstructured":"Srikant, C. B. & Patel, Y. C. Somatostatin receptors on rat pancreatic acinar cells. Pharmacological and structural characterization and demonstration of down-regulation in streptozotocin diabetes. J. Biol. Chem. 261, 7690\u20137696 (1986).","journal-title":"J. Biol. Chem."},{"key":"2098_CR223","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1210\/endo-116-5-1717","volume":"116","author":"CB Srikant","year":"1985","unstructured":"Srikant, C. B. & Patel, Y. C. Somatostatin receptors in the rat adrenal cortex: characterization and comparison with brain and pituitary receptors. Endocrinology 116, 1717\u20131723 (1985).","journal-title":"Endocrinology"},{"key":"2098_CR224","doi-asserted-by":"publisher","first-page":"11151","DOI":"10.1073\/pnas.89.23.11151","volume":"89","author":"JF Bruno","year":"1992","unstructured":"Bruno, J. F., Xu, Y., Song, J. & Berelowitz, M. Molecular cloning and functional expression of a brain-specific somatostatin receptor. Proc. Natl Acad. Sci. USA 89, 11151\u201311155 (1992).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2098_CR225","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1210\/endo-98-2-514","volume":"98","author":"J Drouin","year":"1976","unstructured":"Drouin, J., De L\u00e9an, A., Rainville, D., Lachance, R. & Labrie, F. Characteristics of the interaction between thyrotropin-releasing hormone and somatostatin for thyrotropin and prolactin release. Endocrinology 98, 514\u2013521 (1976).","journal-title":"Endocrinology"},{"key":"2098_CR226","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1210\/endo-108-1-281","volume":"108","author":"UI Richardson","year":"1981","unstructured":"Richardson, U. I. & Schonbrunn, A. Inhibition of adrenocorticotropin secretion by somatostatin in pituitary cells in culture. Endocrinology 108, 281\u2013290 (1981).","journal-title":"Endocrinology"},{"key":"2098_CR227","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1210\/jcem-38-5-742","volume":"38","author":"TM Siler","year":"1974","unstructured":"Siler, T. M., Yen, S. C., Vale, W. & Guillemin, R. Inhibition by somatostatin on the release of TSH induced in man by thyrotropin-releasing factor. J. Clin. Endocrinol. Metab. 38, 742\u2013745 (1974).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2098_CR228","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000201179","volume":"55","author":"T Heintges","year":"1994","unstructured":"Heintges, T., L\u00fcthen, R. & Niederau, C. Inhibition of exocrine pancreatic secretion by somatostatin and its analogues. Digestion 55 (Suppl. 1), 1\u20139 (1994).","journal-title":"Digestion"},{"key":"2098_CR229","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1126\/science.1166308","volume":"190","author":"G Boden","year":"1975","unstructured":"Boden, G., Sivitz, M. C., Owen, O. E., Essa-Koumar, N. & Landor, J. H. Somatostatin suppresses secretin and pancreatic exocrine secretion. Science 190, 163\u2013165 (1975).","journal-title":"Science"},{"key":"2098_CR230","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/cphy.c180035","volume":"10","author":"ML Schubert","year":"2019","unstructured":"Schubert, M. L. & Rehfeld, J. F. Gastric peptides-gastrin and somatostatin. Compr. Physiol. 10, 197\u2013228 (2019).","journal-title":"Compr. Physiol."},{"key":"2098_CR231","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/0026-0495(90)90232-2","volume":"39","author":"GM Makhlouf","year":"1990","unstructured":"Makhlouf, G. M. & Schubert, M. L. Gastric somatostatin: a paracrine regulator of acid secretion. Metabolism 39, 138\u2013142 (1990).","journal-title":"Metabolism"},{"key":"2098_CR232","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/303177a0","volume":"303","author":"KH Jakobs","year":"1983","unstructured":"Jakobs, K. H., Aktories, K. & Schultz, G. A nucleotide regulatory site for somatostatin inhibition of adenylate cyclase in S49 lymphoma cells. Nature 303, 177\u2013178 (1983).","journal-title":"Nature"},{"key":"2098_CR233","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.ceca.2012.01.005","volume":"51","author":"S Mahapatra","year":"2012","unstructured":"Mahapatra, S. et al. Calcium channel types contributing to chromaffin cell excitability, exocytosis and endocytosis. Cell Calcium 51, 321\u2013330 (2012).","journal-title":"Cell Calcium"},{"key":"2098_CR234","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/369336a0","volume":"369","author":"SD Meriney","year":"1994","unstructured":"Meriney, S. D., Gray, D. B. & Pilar, G. R. Somatostatin-induced inhibition of neuronal Ca2+ current modulated by cGMP-dependent protein kinase. Nature 369, 336\u2013339 (1994).","journal-title":"Nature"},{"key":"2098_CR235","doi-asserted-by":"publisher","first-page":"5990","DOI":"10.1016\/S0021-9258(18)53417-7","volume":"268","author":"DR Luthin","year":"1993","unstructured":"Luthin, D. R., Eppler, C. M. & Linden, J. Identification and quantification of Gi-type GTP-binding proteins that copurify with a pituitary somatostatin receptor. J. Biol. Chem. 268, 5990\u20135996 (1993).","journal-title":"J. Biol. Chem."},{"key":"2098_CR236","doi-asserted-by":"publisher","first-page":"101495","DOI":"10.1016\/j.molmet.2022.101495","volume":"61","author":"B Singh","year":"2022","unstructured":"Singh, B., Khattab, F. & Gilon, P. Glucose inhibits glucagon secretion by decreasing [Ca2+]c and by reducing the efficacy of Ca2+ on exocytosis via somatostatin-dependent and independent mechanisms. Mol. Metab. 61, 101495 (2022).","journal-title":"Mol. Metab."},{"key":"2098_CR237","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/0002-9343(88)90397-X","volume":"85","author":"B Draznin","year":"1988","unstructured":"Draznin, B. Intracellular calcium, insulin secretion, and action. Am. J. Med. 85, 44\u201358 (1988).","journal-title":"Am. J. Med."},{"key":"2098_CR238","doi-asserted-by":"publisher","first-page":"187","DOI":"10.2174\/1874467211104030187","volume":"4","author":"S Dalle","year":"2011","unstructured":"Dalle, S., Quoyer, J., Varin, E. & Costes, S. Roles and regulation of the transcription factor CREB in pancreatic \u03b2 -cells. Curr. Mol. Pharmacol. 4, 187\u2013195 (2011).","journal-title":"Curr. Mol. Pharmacol."},{"key":"2098_CR239","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.yfrne.2013.07.005","volume":"34","author":"M Theodoropoulou","year":"2013","unstructured":"Theodoropoulou, M. & Stalla, G. K. Somatostatin receptors: from signaling to clinical practice. Front. Neuroendocrinol. 34, 228\u2013252 (2013).","journal-title":"Front. Neuroendocrinol."},{"key":"2098_CR240","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/j.bbamcr.2011.03.006","volume":"1813","author":"G Kharmate","year":"2011","unstructured":"Kharmate, G. et al. Role of somatostatin receptor 1 and 5 on epidermal growth factor receptor mediated signaling. Biochim. Biophys. Acta 1813, 1172\u20131189 (2011).","journal-title":"Biochim. Biophys. Acta"},{"key":"2098_CR241","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1210\/en.2010-0940","volume":"152","author":"G Kharmate","year":"2011","unstructured":"Kharmate, G. et al. Dissociation of epidermal growth factor receptor and ErbB2 heterodimers in the presence of somatostatin receptor 5 modulate signaling pathways. Endocrinology 152, 931\u2013945 (2011).","journal-title":"Endocrinology"},{"key":"2098_CR242","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1126\/science.256.5060.1215","volume":"256","author":"MG Pan","year":"1992","unstructured":"Pan, M. G., Florio, T. & Stork, P. J. G protein activation of a hormone-stimulated phosphatase in human tumor cells. Science 256, 1215\u20131217 (1992).","journal-title":"Science"},{"key":"2098_CR243","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.mce.2007.08.012","volume":"286","author":"T Florio","year":"2008","unstructured":"Florio, T. Somatostatin\/somatostatin receptor signalling: phosphotyrosine phosphatases. Mol. Cell. Endocrinol. 286, 40\u201348 (2008).","journal-title":"Mol. Cell. Endocrinol."},{"key":"2098_CR244","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2174\/187152011794941154","volume":"11","author":"P L\u00f3pez-Ruiz","year":"2011","unstructured":"L\u00f3pez-Ruiz, P., Rodriguez-Ubreva, J., Cariaga, A. E., Cortes, M. A. & Col\u00e1s, B. SHP-1 in cell-cycle regulation. Anticancer Agents Med. Chem. 11, 89\u201398 (2011).","journal-title":"Anticancer Agents Med. Chem."},{"key":"2098_CR245","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.mce.2015.06.019","volume":"413","author":"SA War","year":"2015","unstructured":"War, S. A., Kim, B. & Kumar, U. Human somatostatin receptor-3 distinctively induces apoptosis in MCF-7 and cell cycle arrest in MDA-MB-231 breast cancer cells. Mol. Cell. Endocrinol. 413, 129\u2013144 (2015).","journal-title":"Mol. Cell. Endocrinol."},{"key":"2098_CR246","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/0304-3835(95)03924-L","volume":"96","author":"E Candi","year":"1995","unstructured":"Candi, E. et al. Tamoxifen and somatostatin affect tumours by inducing apoptosis. Cancer Lett. 96, 141\u2013145 (1995).","journal-title":"Cancer Lett."},{"key":"2098_CR247","doi-asserted-by":"publisher","first-page":"15128","DOI":"10.1074\/jbc.M212315200","volume":"278","author":"C-Y Lin","year":"2003","unstructured":"Lin, C.-Y. et al. Conserved motifs in somatostatin, D2-dopamine, and alpha 2B-adrenergic receptors for inhibiting the Na-H exchanger, NHE1. J. Biol. Chem. 278, 15128\u201315135 (2003).","journal-title":"J. Biol. Chem."},{"key":"2098_CR248","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S0014-5793(96)01159-3","volume":"397","author":"MG Cattaneo","year":"1996","unstructured":"Cattaneo, M. G., Amoroso, D., Gussoni, G., Sanguini, A. M. & Vicentini, L. M. A somatostatin analogue inhibits MAP kinase activation and cell proliferation in human neuroblastoma and in human small cell lung carcinoma cell lines. FEBS Lett. 397, 164\u2013168 (1996).","journal-title":"FEBS Lett."},{"key":"2098_CR249","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/296659a0","volume":"296","author":"K Tatemoto","year":"1982","unstructured":"Tatemoto, K., Carlquist, M. & Mutt, V. Neuropeptide Y-a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature 296, 659\u2013660 (1982).","journal-title":"Nature"},{"key":"2098_CR250","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0196-9781(01)00601-5","volume":"23","author":"E Ekblad","year":"2002","unstructured":"Ekblad, E. & Sundler, F. Distribution of pancreatic polypeptide and peptide YY. Peptides 23, 251\u2013261 (2002).","journal-title":"Peptides"},{"key":"2098_CR251","doi-asserted-by":"publisher","first-page":"4175","DOI":"10.1073\/pnas.78.7.4175","volume":"78","author":"TL Blundell","year":"1981","unstructured":"Blundell, T. L., Pitts, J. E., Tickle, I. J., Wood, S. P. & Wu, C. W. X-ray analysis (1. 4-A resolution) of avian pancreatic polypeptide: Small globular protein hormone. Proc. Natl Acad. Sci. USA 78, 4175\u20134179 (1981).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2098_CR252","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0031-6997(24)01352-8","volume":"50","author":"MC Michel","year":"1998","unstructured":"Michel, M. C. et al. XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol. Rev. 50, 143\u2013150 (1998).","journal-title":"Pharmacol. Rev."},{"key":"2098_CR253","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.peptides.2012.10.010","volume":"39","author":"N Germain","year":"2013","unstructured":"Germain, N. et al. Analogs of pancreatic polypeptide and peptide YY with a locked PP-fold structure are biologically active. Peptides 39, 6\u201310 (2013).","journal-title":"Peptides"},{"key":"2098_CR254","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/S0196-9781(96)00347-6","volume":"18","author":"AA Balasubramaniam","year":"1997","unstructured":"Balasubramaniam, A. A. Neuropeptide Y family of hormones: receptor subtypes and antagonists. Peptides 18, 445\u2013457 (1997).","journal-title":"Peptides"},{"key":"2098_CR255","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.peptides.2017.11.005","volume":"100","author":"RA Lafferty","year":"2018","unstructured":"Lafferty, R. A., Flatt, P. R. & Irwin, N. Emerging therapeutic potential for peptide YY for obesity-diabetes. Peptides 100, 269\u2013274 (2018).","journal-title":"Peptides"},{"key":"2098_CR256","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1056\/NEJMoa1105816","volume":"365","author":"P Sumithran","year":"2011","unstructured":"Sumithran, P. et al. Long-term persistence of hormonal adaptations to weight loss. N. Engl. J. Med. 365, 1597\u20131604 (2011).","journal-title":"N. Engl. J. Med."},{"key":"2098_CR257","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1007\/s00125-014-3292-y","volume":"57","author":"SJ Persaud","year":"2014","unstructured":"Persaud, S. J. & Bewick, G. A. Peptide YY: more than just an appetite regulator. Diabetologia 57, 1762\u20131769 (2014).","journal-title":"Diabetologia"},{"key":"2098_CR258","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.1016\/j.febslet.2014.07.005","volume":"588","author":"W Kim","year":"2014","unstructured":"Kim, W. et al. Pancreatic polypeptide inhibits somatostatin secretion. FEBS Lett. 588, 3233\u20133239 (2014).","journal-title":"FEBS Lett."},{"key":"2098_CR259","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.bbagen.2014.11.005","volume":"1850","author":"F Arag\u00f3n","year":"2015","unstructured":"Arag\u00f3n, F. et al. Pancreatic polypeptide regulates glucagon release through PPYR1 receptors expressed in mouse and human alpha-cells. Biochim. Biophys. Acta 1850, 343\u2013351 (2015).","journal-title":"Biochim. Biophys. Acta"},{"key":"2098_CR260","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.npep.2012.08.005","volume":"46","author":"P Holzer","year":"2012","unstructured":"Holzer, P., Reichmann, F. & Farzi, A. Neuropeptide Y, peptide YY and pancreatic polypeptide in the gut-brain axis. Neuropeptides 46, 261\u2013274 (2012).","journal-title":"Neuropeptides"},{"key":"2098_CR261","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.peptides.2006.09.024","volume":"28","author":"S Kojima","year":"2007","unstructured":"Kojima, S. et al. A role for pancreatic polypeptide in feeding and body weight regulation. Peptides 28, 459\u2013463 (2007).","journal-title":"Peptides"},{"key":"2098_CR262","doi-asserted-by":"publisher","first-page":"170923","DOI":"10.1016\/j.peptides.2022.170923","volume":"160","author":"W Zhu","year":"2023","unstructured":"Zhu, W., Tanday, N., Flatt, P. R. & Irwin, N. Pancreatic polypeptide revisited: Potential therapeutic effects in obesity-diabetes. Peptides 160, 170923 (2023).","journal-title":"Peptides"},{"key":"2098_CR263","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S0039-6109(16)46080-9","volume":"73","author":"LJ Skandalakis","year":"1993","unstructured":"Skandalakis, L. J., Rowe, J. S., Gray, S. W. & Skandalakis, J. E. Surgical embryology and anatomy of the pancreas. Surg. Clin. North Am. 73, 661\u2013697 (1993).","journal-title":"Surg. Clin. North Am."},{"key":"2098_CR264","first-page":"2633","volume":"1","author":"A Ribet","year":"1972","unstructured":"Ribet, A., Pascal, J. P. & Frexinos, J. [The exocrine pancreas. I. Structure and functions]. Nouv. Presse Med. 1, 2633\u20132640 (1972).","journal-title":"Nouv. Presse Med."},{"key":"2098_CR265","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1053\/j.gastro.2004.05.002","volume":"127","author":"C Owyang","year":"2004","unstructured":"Owyang, C. & Logsdon, C. D. New insights into neurohormonal regulation of pancreatic secretion. Gastroenterology 127, 957\u2013969 (2004).","journal-title":"Gastroenterology"},{"key":"2098_CR266","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1469-185X.1978.tb01437.x","volume":"53","author":"RM Case","year":"1978","unstructured":"Case, R. M. Synthesis, intracellular transport and discharge of exportable proteins in the pancreatic acinar cell and other cells. Biol. Rev. Camb. Philos. Soc. 53, 211\u2013354 (1978).","journal-title":"Biol. Rev. Camb. Philos. Soc."},{"key":"2098_CR267","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1097\/MPA.0000000000000421","volume":"44","author":"P Pallagi","year":"2015","unstructured":"Pallagi, P., Hegyi, P. & Rakonczay, Z. The physiology and pathophysiology of pancreatic ductal secretion: the background for clinicians. Pancreas 44, 1211\u20131233 (2015).","journal-title":"Pancreas"},{"key":"2098_CR268","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1152\/physrev.1981.61.2.296","volume":"61","author":"A Roos","year":"1981","unstructured":"Roos, A. & Boron, W. F. Intracellular pH. Physiol. Rev. 61, 296\u2013434 (1981).","journal-title":"Physiol. Rev."},{"key":"2098_CR269","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1590\/S0100-879X2009000100003","volume":"42","author":"OH Petersen","year":"2009","unstructured":"Petersen, O. H. Ca2+ signaling in pancreatic acinar cells: physiology and pathophysiology. Braz. J. Med. Biol. Res. Rev. Bras. Pesqui. Med. E Biol. 42, 9\u201316 (2009).","journal-title":"Braz. J. Med. Biol. Res. Rev. Bras. Pesqui. Med. E Biol."},{"key":"2098_CR270","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/361315a0","volume":"361","author":"MJ Berridge","year":"1993","unstructured":"Berridge, M. J. Inositol trisphosphate and calcium signalling. Nature 361, 315\u2013325 (1993).","journal-title":"Nature"},{"key":"2098_CR271","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1097\/MOG.0b013e32830b110c","volume":"24","author":"JA Williams","year":"2008","unstructured":"Williams, J. A. Receptor-mediated signal transduction pathways and the regulation of pancreatic acinar cell function. Curr. Opin. Gastroenterol. 24, 573\u2013579 (2008).","journal-title":"Curr. Opin. Gastroenterol."},{"key":"2098_CR272","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1159\/000201524","volume":"58","author":"JA Williams","year":"1997","unstructured":"Williams, J. A., Groblewski, G. E., Ohnishi, H. & Yule, D. I. Stimulus-secretion coupling of pancreatic digestive enzyme secretion. Digestion 58 (Suppl. 1), 42\u201345 (1997).","journal-title":"Digestion"},{"key":"2098_CR273","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1146\/annurev.physiol.67.041703.084745","volume":"67","author":"JE Melvin","year":"2005","unstructured":"Melvin, J. E., Yule, D., Shuttleworth, T. & Begenisich, T. Regulation of fluid and electrolyte secretion in salivary gland acinar cells. Annu. Rev. Physiol. 67, 445\u2013469 (2005).","journal-title":"Annu. Rev. Physiol."},{"key":"2098_CR274","first-page":"29","volume":"1","author":"S Afroze","year":"2013","unstructured":"Afroze, S. et al. The physiological roles of secretin and its receptor. Ann. Transl. Med. 1, 29 (2013).","journal-title":"Ann. Transl. Med."},{"key":"2098_CR275","first-page":"193","volume":"119","author":"D Yang","year":"2009","unstructured":"Yang, D. et al. IRBIT coordinates epithelial fluid and HCO3- secretion by stimulating the transporters pNBC1 and CFTR in the murine pancreatic duct. J. Clin. Invest. 119, 193\u2013202 (2009).","journal-title":"J. Clin. Invest."},{"key":"2098_CR276","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/374421a0","volume":"374","author":"DM Cooper","year":"1995","unstructured":"Cooper, D. M., Mons, N. & Karpen, J. W. Adenylyl cyclases and the interaction between calcium and cAMP signalling. Nature 374, 421\u2013424 (1995).","journal-title":"Nature"},{"key":"2098_CR277","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1034\/j.1600-0773.2002.910610.x","volume":"91","author":"B Ji","year":"2002","unstructured":"Ji, B., Bi, Y., Simeone, D., Mortensen, R. M. & Logsdon, C. D. Human pancreatic acinar cells do not respond to cholecystokinin. Pharmacol. Toxicol. 91, 327\u2013332 (2002).","journal-title":"Pharmacol. Toxicol."},{"key":"2098_CR278","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1053\/gast.2001.29557","volume":"121","author":"B Ji","year":"2001","unstructured":"Ji, B., Bi, Y., Simeone, D., Mortensen, R. M. & Logsdon, C. D. Human pancreatic acinar cells lack functional responses to cholecystokinin and gastrin. Gastroenterology 121, 1380\u20131390 (2001).","journal-title":"Gastroenterology"},{"key":"2098_CR279","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1053\/j.gastro.2008.05.026","volume":"135","author":"JA Murphy","year":"2008","unstructured":"Murphy, J. A. et al. Direct activation of cytosolic Ca2+ signaling and enzyme secretion by cholecystokinin in human pancreatic acinar cells. Gastroenterology 135, 632\u2013641 (2008).","journal-title":"Gastroenterology"},{"key":"2098_CR280","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0016-5085(19)33807-7","volume":"59","author":"AM Brooks","year":"1970","unstructured":"Brooks, A. M. & Grossman, M. I. Postprandial pH and neutralizing capacity of the proximal duodenum in dogs. Gastroenterology 59, 85\u201389 (1970).","journal-title":"Gastroenterology"},{"key":"2098_CR281","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/dom.12993","volume":"19","author":"A Tengholm","year":"2017","unstructured":"Tengholm, A. & Gylfe, E. cAMP signalling in insulin and glucagon secretion. Diabetes Obes. Metab. 19 (Suppl. 1), 42\u201353 (2017).","journal-title":"Diabetes Obes. Metab."},{"key":"2098_CR282","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1152\/physrev.00011.2011","volume":"92","author":"MG Lee","year":"2012","unstructured":"Lee, M. G., Ohana, E., Park, H. W., Yang, D. & Muallem, S. Molecular mechanism of pancreatic and salivary glands fluid and HCO3\u2212 secretion. Physiol. Rev. 92, 39\u201374 (2012).","journal-title":"Physiol. Rev."},{"key":"2098_CR283","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S0016-5085(83)80227-3","volume":"85","author":"CH You","year":"1983","unstructured":"You, C. H., Rominger, J. M. & Chey, W. Y. Potentiation effect of cholecystokinin-octapeptide on pancreatic bicarbonate secretion stimulated by a physiologic dose of secretin in humans. Gastroenterology 85, 40\u201345 (1983).","journal-title":"Gastroenterology"},{"key":"2098_CR284","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.ceca.2006.08.009","volume":"40","author":"K Kiselyov","year":"2006","unstructured":"Kiselyov, K., Wang, X., Shin, D. M., Zang, W. & Muallem, S. Calcium signaling complexes in microdomains of polarized secretory cells. Cell Calcium 40, 451\u2013459 (2006).","journal-title":"Cell Calcium"},{"key":"2098_CR285","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejphar.2003.08.042","volume":"481","author":"SJ Konturek","year":"2003","unstructured":"Konturek, S. J., Zabielski, R., Konturek, J. W. & Czarnecki, J. Neuroendocrinology of the pancreas; role of brain\u2013gut axis in pancreatic secretion. Eur. J. Pharmacol. 481, 1\u201314 (2003).","journal-title":"Eur. J. Pharmacol."},{"key":"2098_CR286","first-page":"12","volume":"18","author":"I Novak","year":"2003","unstructured":"Novak, I. ATP as a signaling molecule: the exocrine focus. N. Physiol. Sci. 18, 12\u201317 (2003).","journal-title":"N. Physiol. Sci."},{"key":"2098_CR287","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1159\/000055831","volume":"1","author":"WY Chey","year":"2001","unstructured":"Chey, W. Y. & Chang, T. Neural hormonal regulation of exocrine pancreatic secretion. Pancreatol. 1, 320\u2013335 (2001).","journal-title":"Pancreatol."},{"key":"2098_CR288","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1679\/aohc.55.453","volume":"55","author":"T Murakami","year":"1992","unstructured":"Murakami, T. & Fujita, T. Microcirculation of the rat pancreas, with special reference to the insulo-acinar portal and insulo-venous drainage systems: a further scanning electron microscope study of corrosion casts. Arch. Histol. Cytol. 55, 453\u2013476 (1992).","journal-title":"Arch. Histol. Cytol."},{"key":"2098_CR289","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/(SICI)1097-0029(19970601)37:5\/6<478::AID-JEMT10>3.0.CO;2-N","volume":"37","author":"T Murakami","year":"1997","unstructured":"Murakami, T., Hitomi, S., Ohtsuka, A., Taguchi, T. & Fujita, T. Pancreatic insulo-acinar portal systems in humans, rats, and some other mammals: scanning electron microscopy of vascular casts. Microsc. Res. Tech. 37, 478\u2013488 (1997).","journal-title":"Microsc. Res. Tech."},{"key":"2098_CR290","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1159\/000064718","volume":"2","author":"PM Pour","year":"2002","unstructured":"Pour, P. M., Standop, J. & Batra, S. K. Are islet cells the gatekeepers of the pancreas?. Pancreatology 2, 440\u2013448 (2002).","journal-title":"Pancreatology"},{"key":"2098_CR291","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S0140-6736(69)90171-8","volume":"2","author":"JR Henderson","year":"1969","unstructured":"Henderson, J. R. Why are the islets of Langerhans? Lancet Lond. Engl. 2, 469\u2013470 (1969).","journal-title":"Lancet Lond. Engl."},{"key":"2098_CR292","first-page":"79","volume":"42","author":"AA Aughsteen","year":"1993","unstructured":"Aughsteen, A. A. & Kataoka, K. Morphometric studies on the juxta-insular and tele-insular acinar cells of the pancreas in normal and streptozotocin-induced diabetic rats. J. Electron Microsc. 42, 79\u201387 (1993).","journal-title":"J. Electron Microsc."},{"key":"2098_CR293","first-page":"G487","volume":"251","author":"CD Logsdon","year":"1986","unstructured":"Logsdon, C. D. Stimulation of pancreatic acinar cell growth by CCK, epidermal growth factor, and insulin in vitro. Am. J. Physiol. 251, G487\u2013G494 (1986).","journal-title":"Am. J. Physiol."},{"key":"2098_CR294","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1016\/j.cmet.2023.10.003","volume":"35","author":"AMY Zhang","year":"2023","unstructured":"Zhang, A. M. Y. et al. Hyperinsulinemia acts via acinar insulin receptors to initiate pancreatic cancer by increasing digestive enzyme production and inflammation. Cell Metab. 35, 2119\u20132135.e5 (2023).","journal-title":"Cell Metab."},{"key":"2098_CR295","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s00109-020-01887-x","volume":"98","author":"SM Hartig","year":"2020","unstructured":"Hartig, S. M. & Cox, A. R. Paracrine signaling in islet function and survival. J. Mol. Med. Berl. Ger. 98, 451\u2013467 (2020).","journal-title":"J. Mol. Med. Berl. Ger."},{"key":"2098_CR296","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1016\/j.cmet.2023.05.007","volume":"35","author":"G Basile","year":"2023","unstructured":"Basile, G. et al. Excess pancreatic elastase alters acinar-\u03b2 cell communication by impairing the mechano-signaling and the PAR2 pathways. Cell Metab. 35, 1242\u20131260.e9 (2023).","journal-title":"Cell Metab."},{"key":"2098_CR297","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel, R. L., Giaquinto, A. N. & Jemal, A. Cancer statistics, 2024. Ca. Cancer J. Clin. 74, 12\u201349 (2024).","journal-title":"Ca. Cancer J. Clin."},{"key":"2098_CR298","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","volume":"74","author":"L Rahib","year":"2014","unstructured":"Rahib, L. et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 74, 2913\u20132921 (2014).","journal-title":"Cancer Res."},{"key":"2098_CR299","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.3748\/wjg.v24.i19.2047","volume":"24","author":"L Zhang","year":"2018","unstructured":"Zhang, L., Sanagapalli, S. & Stoita, A. Challenges in diagnosis of pancreatic cancer. World J. Gastroenterol. 24, 2047\u20132060 (2018).","journal-title":"World J. Gastroenterol."},{"key":"2098_CR300","first-page":"44","volume":"1815","author":"S Chakraborty","year":"2011","unstructured":"Chakraborty, S., Baine, M. J., Sasson, A. R. & Batra, S. K. Current status of molecular markers for early detection of sporadic pancreatic cancer. Biochim. Biophys. Acta 1815, 44\u201364 (2011).","journal-title":"Biochim. Biophys. Acta"},{"key":"2098_CR301","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1053\/j.gastro.2008.01.039","volume":"134","author":"R Pannala","year":"2008","unstructured":"Pannala, R. et al. Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus. Gastroenterology 134, 981\u2013987 (2008).","journal-title":"Gastroenterology"},{"key":"2098_CR302","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/JP9.0000000000000146","volume":"6","author":"R Gong","year":"2023","unstructured":"Gong, R., Hu, Y., Yu, Q., Fang, L. & Ren, H. Metabolic signatures in pancreatic ductal adenocarcinoma: diagnostic and therapeutic implications. J. Pancreatol. 6, 185 (2023).","journal-title":"J. Pancreatol."},{"key":"2098_CR303","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1053\/j.gastro.2007.10.040","volume":"134","author":"ST Chari","year":"2008","unstructured":"Chari, S. T. et al. Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer. Gastroenterology 134, 95\u2013101 (2008).","journal-title":"Gastroenterology"},{"key":"2098_CR304","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1097\/JP9.0000000000000137","volume":"6","author":"S Rafaqat","year":"2023","unstructured":"Rafaqat, S., Hafeez, R., Mairaj, R., Saleem, A. & Rafaqat, S. Pancreatic biomarkers: role in diabetes mellitus. J. Pancreatol. 6, 169 (2023).","journal-title":"J. Pancreatol."},{"key":"2098_CR305","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1053\/j.gastro.2021.10.017","volume":"162","author":"AF Peery","year":"2022","unstructured":"Peery, A. F. et al. Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: update 2021. Gastroenterology 162, 621\u2013644 (2022).","journal-title":"Gastroenterology"},{"key":"2098_CR306","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1136\/gutjnl-2012-302779","volume":"62","author":"PA Banks","year":"2013","unstructured":"Banks, P. A. et al. Classification of acute pancreatitis\u20142012: revision of the Atlanta classification and definitions by international consensus. Gut 62, 102\u2013111 (2013).","journal-title":"Gut"},{"key":"2098_CR307","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1016\/S0140-6736(16)00097-0","volume":"387","author":"S Majumder","year":"2016","unstructured":"Majumder, S. & Chari, S. T. Chronic pancreatitis. Lancet Lond. Engl. 387, 1957\u20131966 (2016).","journal-title":"Lancet Lond. Engl."},{"key":"2098_CR308","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.3748\/wjg.v29.i7.1194","volume":"29","author":"WB Strum","year":"2023","unstructured":"Strum, W. B. & Boland, C. R. Advances in acute and chronic pancreatitis. World J. Gastroenterol. 29, 1194\u20131201 (2023).","journal-title":"World J. Gastroenterol."},{"key":"2098_CR309","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003251","volume":"95","author":"J Pan","year":"2016","unstructured":"Pan, J. et al. Risk factors for diabetes mellitus in chronic pancreatitis: a cohort of 2,011 patients. Medicine 95, e3251 (2016).","journal-title":"Medicine"},{"key":"2098_CR310","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-017-1193-9","volume":"15","author":"MM Rafeeq","year":"2017","unstructured":"Rafeeq, M. M. & Murad, H. A. S. Cystic fibrosis: current therapeutic targets and future approaches. J. Transl. Med. 15, 84 (2017).","journal-title":"J. Transl. Med."},{"key":"2098_CR311","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1126\/science.7543698","volume":"269","author":"MJ Stutts","year":"1995","unstructured":"Stutts, M. J. et al. CFTR as a cAMP-dependent regulator of sodium channels. Science 269, 847\u2013850 (1995).","journal-title":"Science"},{"key":"2098_CR312","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1172\/JCI117789","volume":"95","author":"LG Johnson","year":"1995","unstructured":"Johnson, L. G., Boyles, S. E., Wilson, J. & Boucher, R. C. Normalization of raised sodium absorption and raised calcium-mediated chloride secretion by adenovirus-mediated expression of cystic fibrosis transmembrane conductance regulator in primary human cystic fibrosis airway epithelial cells. J. Clin. Invest. 95, 1377\u20131382 (1995).","journal-title":"J. Clin. Invest."},{"key":"2098_CR313","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1001\/jama.2021.23280","volume":"327","author":"TM Endres","year":"2022","unstructured":"Endres, T. M. & Konstan, M. W. What is cystic fibrosis? JAMA 327, 191 (2022).","journal-title":"JAMA"},{"key":"2098_CR314","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.2337\/dc09-0586","volume":"32","author":"A Moran","year":"2009","unstructured":"Moran, A. et al. Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality. Diabetes Care 32, 1626\u20131631 (2009).","journal-title":"Diabetes Care"},{"key":"2098_CR315","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.2337\/dc08-0466","volume":"31","author":"AI Adler","year":"2008","unstructured":"Adler, A. I., Shine, B. S. F., Chamnan, P., Haworth, C. S. & Bilton, D. Genetic determinants and epidemiology of cystic fibrosis-related diabetes: results from a British cohort of children and adults. Diabetes Care 31, 1789\u20131794 (2008).","journal-title":"Diabetes Care"},{"key":"2098_CR316","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.2337\/dc11-2327","volume":"35","author":"PA Gottlieb","year":"2012","unstructured":"Gottlieb, P. A. et al. No relation between cystic fibrosis-related diabetes and type 1 diabetes autoimmunity. Diabetes Care 35, e57 (2012).","journal-title":"Diabetes Care"},{"key":"2098_CR317","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/ppul.1142","volume":"32","author":"C Koch","year":"2001","unstructured":"Koch, C. et al. Presence of cystic fibrosis-related diabetes mellitus is tightly linked to poor lung function in patients with cystic fibrosis: data from the European Epidemiologic Registry of Cystic Fibrosis. Pediatr. Pulmonol. 32, 343\u2013350 (2001).","journal-title":"Pediatr. Pulmonol."},{"key":"2098_CR318","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1164\/rccm.201512-2518OC","volume":"194","author":"Y Yi","year":"2016","unstructured":"Yi, Y. et al. Abnormal glucose tolerance in infants and young children with cystic fibrosis. Am. J. Respir. Crit. Care Med. 194, 974\u2013980 (2016).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2098_CR319","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/j.1399-5448.2009.00632.x","volume":"11","author":"KL Ode","year":"2010","unstructured":"Ode, K. L. et al. Oral glucose tolerance testing in children with cystic fibrosis. Pediatr. Diabetes 11, 487\u2013492 (2010).","journal-title":"Pediatr. Diabetes"},{"key":"2098_CR320","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/j.1651-2227.1993.tb12653.x","volume":"82","author":"T Arrigo","year":"1993","unstructured":"Arrigo, T. et al. Longitudinal evaluation of glucose tolerance and insulin secretion in non-diabetic children and adolescents with cystic fibrosis: results of a two-year follow-up. Acta Paediatr. 82, 249\u2013253 (1993).","journal-title":"Acta Paediatr."},{"key":"2098_CR321","doi-asserted-by":"publisher","first-page":"134","DOI":"10.2337\/db16-0394","volume":"66","author":"S Sheikh","year":"2017","unstructured":"Sheikh, S. et al. Reduced \u03b2-cell secretory capacity in pancreatic-insufficient, but not pancreatic-sufficient, cystic fibrosis despite normal glucose tolerance. Diabetes 66, 134\u2013144 (2017).","journal-title":"Diabetes"},{"key":"2098_CR322","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.jcf.2019.08.016","volume":"18","author":"A Granados","year":"2019","unstructured":"Granados, A. et al. Cystic fibrosis related diabetes: Pathophysiology, screening and diagnosis. J. Cyst. Fibros. 18 (Suppl. 1), S3\u2013S9 (2019).","journal-title":"J. Cyst. Fibros."},{"key":"2098_CR323","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","volume":"402","author":"KL Ong","year":"2023","unstructured":"Ong, K. L. et al. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet 402, 203\u2013234 (2023).","journal-title":"Lancet"},{"key":"2098_CR324","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.2337\/dc11-S062","volume":"34","author":"American Diabetes Association","year":"2011","unstructured":"American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 34, S62\u2013S69 (2011).","journal-title":"Diabetes Care"},{"key":"2098_CR325","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1002\/dmrr.2260","volume":"28","author":"N Ewald","year":"2012","unstructured":"Ewald, N. et al. Prevalence of diabetes mellitus secondary to pancreatic diseases (type 3c). Diabetes Metab. Res. Rev. 28, 338\u2013342 (2012).","journal-title":"Diabetes Metab. Res. Rev."},{"key":"2098_CR326","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/S2468-1253(16)30106-6","volume":"1","author":"PA Hart","year":"2016","unstructured":"Hart, P. A. et al. Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer. Lancet Gastroenterol. Hepatol. 1, 226\u2013237 (2016).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"2098_CR327","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1620\/tjem.252.353","volume":"252","author":"T Takikawa","year":"2020","unstructured":"Takikawa, T. et al. New-onset or exacerbation of diabetes mellitus is a clue to the early diagnosis of pancreatic cancer. Tohoku J. Exp. Med. 252, 353\u2013364 (2020).","journal-title":"Tohoku J. Exp. Med."},{"key":"2098_CR328","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1001\/jama.1995.03520440059037","volume":"273","author":"J Everhart","year":"1995","unstructured":"Everhart, J. & Wright, D. Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis. JAMA 273, 1605\u20131609 (1995).","journal-title":"JAMA"},{"key":"2098_CR329","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1038\/sj.bjc.6602619","volume":"92","author":"R Huxley","year":"2005","unstructured":"Huxley, R., Ansary-Moghaddam, A., Berrington de Gonz\u00e1lez, A., Barzi, F. & Woodward, M. Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br. J. Cancer 92, 2076\u20132083 (2005).","journal-title":"Br. J. Cancer"},{"key":"2098_CR330","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s10552-010-9686-3","volume":"22","author":"D Li","year":"2011","unstructured":"Li, D. et al. Diabetes and risk of pancreatic cancer: a pooled analysis of three large case-control studies. Cancer Causes Control 22, 189\u2013197 (2011).","journal-title":"Cancer Causes Control"},{"key":"2098_CR331","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1016\/j.ejca.2011.03.003","volume":"47","author":"Q Ben","year":"2011","unstructured":"Ben, Q. et al. Diabetes mellitus and risk of pancreatic cancer: a meta-analysis of cohort studies. Eur. J. Cancer 47, 1928\u20131937 (2011).","journal-title":"Eur. J. Cancer"},{"key":"2098_CR332","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.gastro.2005.05.007","volume":"129","author":"ST Chari","year":"2005","unstructured":"Chari, S. T. et al. Probability of pancreatic cancer following diabetes: a population-based study. Gastroenterology 129, 504\u2013511 (2005).","journal-title":"Gastroenterology"},{"key":"2098_CR333","doi-asserted-by":"publisher","DOI":"10.1172\/JCI146788","volume":"131","author":"T Mezza","year":"2021","unstructured":"Mezza, T. et al. Pancreaticoduodenectomy model demonstrates a fundamental role of dysfunctional \u03b2 cells in predicting diabetes. J. Clin. Invest. 131, e146788 (2021).","journal-title":"J. Clin. Invest."},{"key":"2098_CR334","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1053\/j.gastro.2008.10.083","volume":"136","author":"H Schrader","year":"2009","unstructured":"Schrader, H. et al. Reduced pancreatic volume and beta-cell area in patients with chronic pancreatitis. Gastroenterology 136, 513\u2013522 (2009).","journal-title":"Gastroenterology"},{"key":"2098_CR335","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1210\/jc.2018-00968","volume":"104","author":"J Sun","year":"2019","unstructured":"Sun, J. et al. \u03b2-cell dedifferentiation in patients with T2D with adequate glucose control and nondiabetic chronic pancreatitis. J. Clin. Endocrinol. Metab. 104, 83\u201394 (2019).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2098_CR336","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1177\/0963689718755707","volume":"27","author":"MA Webb","year":"2018","unstructured":"Webb, M. A., Chen, J. J., James, R. F. L., Davies, M. J. & Dennison, A. R. Elevated levels of alpha cells emanating from the pancreatic ducts of a patient with a low BMI and chronic pancreatitis. Cell Transpl. 27, 902\u2013906 (2018).","journal-title":"Cell Transpl."},{"key":"2098_CR337","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1097\/MPA.0000000000000491","volume":"45","author":"R Lundberg","year":"2016","unstructured":"Lundberg, R. et al. Early alterations in glycemic control and pancreatic endocrine function in nondiabetic patients with chronic pancreatitis. Pancreas 45, 565\u2013571 (2016).","journal-title":"Pancreas"},{"key":"2098_CR338","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s00535-008-2249-7","volume":"43","author":"K Shimizu","year":"2008","unstructured":"Shimizu, K. Mechanisms of pancreatic fibrosis and applications to the treatment of chronic pancreatitis. J. Gastroenterol. 43, 823\u2013832 (2008).","journal-title":"J. Gastroenterol."},{"key":"2098_CR339","doi-asserted-by":"publisher","first-page":"S48","DOI":"10.1016\/j.cgh.2009.07.038","volume":"7","author":"A Masamune","year":"2009","unstructured":"Masamune, A., Watanabe, T., Kikuta, K. & Shimosegawa, T. Roles of pancreatic stellate cells in pancreatic inflammation and fibrosis. Clin. Gastroenterol. Hepatol. 7, S48\u2013S54 (2009).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"2098_CR340","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1097\/MOG.0000000000001055","volume":"40","author":"A Pichardo-Lowden","year":"2024","unstructured":"Pichardo-Lowden, A., Goodarzi, M. O., Trikudanathan, G., Serrano, J. & Dungan, K. M. Risk and factors determining diabetes after mild, nonnecrotizing acute pancreatitis. Curr. Opin. Gastroenterol. 40, 396\u2013403 (2024).","journal-title":"Curr. Opin. Gastroenterol."},{"key":"2098_CR341","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1016\/S0140-6736(20)32542-3","volume":"397","author":"M Shteinberg","year":"2021","unstructured":"Shteinberg, M., Haq, I. J., Polineni, D. & Davies, J. C. Cystic fibrosis. Lancet 397, 2195\u20132211 (2021).","journal-title":"Lancet"},{"key":"2098_CR342","doi-asserted-by":"publisher","first-page":"a009746","DOI":"10.1101\/cshperspect.a009746","volume":"3","author":"M Wilschanski","year":"2013","unstructured":"Wilschanski, M. & Novak, I. The cystic fibrosis of exocrine pancreas. Cold Spring Harb. Perspect. Med. 3, a009746 (2013).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"2098_CR343","first-page":"602","volume":"110","author":"FW Abdul-Karim","year":"1986","unstructured":"Abdul-Karim, F. W., Dahms, B. B., Velasco, M. E. & Rodman, H. M. Islets of langerhans in adolescents and adults with cystic fibrosis. A quantitative study. Arch. Pathol. Lab. Med. 110, 602\u2013606 (1986).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"2098_CR344","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3109\/15513818609025923","volume":"6","author":"K Soejima","year":"1986","unstructured":"Soejima, K. & Landing, B. H. Pancreatic islets in older patients with cystic fibrosis with and without diabetes mellitus: morphometric and immunocytologic studies. Pediatr. Pathol. 6, 25\u201346 (1986).","journal-title":"Pediatr. Pathol."},{"key":"2098_CR345","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/S0022-3476(05)80032-0","volume":"118","author":"A Moran","year":"1991","unstructured":"Moran, A., Diem, P., Klein, D. J., Levitt, M. D. & Robertson, R. P. Pancreatic endocrine function in cystic fibrosis. J. Pediatr. 118, 715\u2013723 (1991).","journal-title":"J. Pediatr."},{"key":"2098_CR346","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.jcf.2013.02.008","volume":"12","author":"A Kelly","year":"2013","unstructured":"Kelly, A. & Moran, A. Update on cystic fibrosis-related diabetes. J. Cyst. Fibros. 12, 318\u2013331 (2013).","journal-title":"J. Cyst. Fibros."},{"key":"2098_CR347","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17404-z","volume":"7","author":"M Bogdani","year":"2017","unstructured":"Bogdani, M. et al. Structural abnormalities in islets from very young children with cystic fibrosis may contribute to cystic fibrosis-related diabetes. Sci. Rep. 7, 17231 (2017).","journal-title":"Sci. Rep."},{"key":"2098_CR348","doi-asserted-by":"publisher","first-page":"R35","DOI":"10.1530\/JOE-18-0468","volume":"241","author":"AW Norris","year":"2019","unstructured":"Norris, A. W. et al. Survival in a bad neighborhood: pancreatic islets in cystic fibrosis. J. Endocrinol. 241, R35\u2013R50 (2019).","journal-title":"J. Endocrinol."},{"key":"2098_CR349","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1159\/000055786","volume":"1","author":"PG Lankisch","year":"2001","unstructured":"Lankisch, P. G. Natural course of chronic pancreatitis. Pancreatology 1, 3\u201314 (2001).","journal-title":"Pancreatology"},{"key":"2098_CR350","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1097\/MPA.0000000000000479","volume":"45","author":"R Talukdar","year":"2016","unstructured":"Talukdar, R. et al. T-helper cell\u2013mediated islet inflammation contributes to \u03b2-cell dysfunction in chronic pancreatitis. Pancreas 45, 434\u2013442 (2016).","journal-title":"Pancreas"},{"key":"2098_CR351","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1152\/physiol.00032.2009","volume":"24","author":"MY Donath","year":"2009","unstructured":"Donath, M. Y., B\u00f6ni-Schnetzler, M., Ellingsgaard, H. & Ehses, J. A. Islet inflammation impairs the pancreatic beta-cell in type 2 diabetes. Physiology 24, 325\u2013331 (2009).","journal-title":"Physiology"},{"key":"2098_CR352","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/nrendo.2009.21","volume":"5","author":"DL Eizirik","year":"2009","unstructured":"Eizirik, D. L., Colli, M. L. & Ortis, F. The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nat. Rev. Endocrinol. 5, 219\u2013226 (2009).","journal-title":"Nat. Rev. Endocrinol."},{"key":"2098_CR353","doi-asserted-by":"publisher","first-page":"676","DOI":"10.3390\/ijms20030676","volume":"20","author":"A Padoan","year":"2019","unstructured":"Padoan, A., Plebani, M. & Basso, D. Inflammation and pancreatic cancer: focus on metabolism, cytokines, and immunity. Int. J. Mol. Sci. 20, 676 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"2098_CR354","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-12-92","volume":"12","author":"L Tan","year":"2014","unstructured":"Tan, L. et al. Macrophage migration inhibitory factor is overexpressed in pancreatic cancer tissues and impairs insulin secretion function of \u03b2-cell. J. Transl. Med. 12, 92 (2014).","journal-title":"J. Transl. Med."},{"key":"2098_CR355","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s00125-014-3481-8","volume":"58","author":"W Gao","year":"2015","unstructured":"Gao, W. et al. Analysis of global gene expression profiles suggests a role of acute inflammation in type 3C diabetes mellitus caused by pancreatic ductal adenocarcinoma. Diabetologia 58, 835\u2013844 (2015).","journal-title":"Diabetologia"},{"key":"2098_CR356","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1073\/pnas.90.5.1731","volume":"90","author":"JA Corbett","year":"1993","unstructured":"Corbett, J. A., Sweetland, M. A., Wang, J. L., Lancaster, J. R. & McDaniel, M. L. Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans. Proc. Natl Acad. Sci. USA 90, 1731\u20131735 (1993).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2098_CR357","doi-asserted-by":"publisher","first-page":"5218","DOI":"10.1210\/en.2009-0543","volume":"150","author":"M B\u00f6ni-Schnetzler","year":"2009","unstructured":"B\u00f6ni-Schnetzler, M. et al. Free fatty acids induce a proinflammatory response in islets via the abundantly expressed interleukin-1 receptor I. Endocrinology 150, 5218\u20135229 (2009).","journal-title":"Endocrinology"},{"key":"2098_CR358","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/nrd4275","volume":"13","author":"MY Donath","year":"2014","unstructured":"Donath, M. Y. Targeting inflammation in the treatment of type 2 diabetes: time to start. Nat. Rev. Drug Discov. 13, 465\u2013476 (2014).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2098_CR359","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1007\/s10620-012-2086-7","volume":"57","author":"M Sasikala","year":"2012","unstructured":"Sasikala, M. et al. \u03b2-Cell dysfunction in chronic pancreatitis. Dig. Dis. Sci. 57, 1764\u20131772 (2012).","journal-title":"Dig. Dis. Sci."},{"key":"2098_CR360","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1007\/s001250100021","volume":"44","author":"DL Eizirik","year":"2001","unstructured":"Eizirik, D. L. & Mandrup-Poulsen, T. A choice of death - the signal-transduction of immune-mediated beta-cell apoptosis. Diabetologia 44, 2115\u20132133 (2001).","journal-title":"Diabetologia"},{"key":"2098_CR361","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1089\/jir.2014.0082","volume":"35","author":"PK Pondugala","year":"2015","unstructured":"Pondugala, P. K., Sasikala, M., Guduru, V. R., Rebala, P. & Nageshwar Reddy, D. Interferon-\u03b3 decreases nuclear localization of Pdx-1 and triggers \u03b2-cell dysfunction in chronic pancreatitis. J. Interferon Cytokine Res. 35, 523\u2013529 (2015).","journal-title":"J. Interferon Cytokine Res."},{"key":"2098_CR362","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s13287-017-0694-z","volume":"8","author":"Y Zhu","year":"2017","unstructured":"Zhu, Y., Liu, Q., Zhou, Z. & Ikeda, Y. PDX1, neurogenin-3, and MAFA: critical transcription regulators for beta cell development and regeneration. Stem Cell Res. Ther. 8, 240 (2017).","journal-title":"Stem Cell Res. Ther."},{"key":"2098_CR363","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1097\/MPA.0b013e3181d6bc69","volume":"39","author":"S Mitnala","year":"2010","unstructured":"Mitnala, S. et al. Reduced expression of PDX-1 is associated with decreased beta cell function in chronic pancreatitis. Pancreas 39, 856\u2013862 (2010).","journal-title":"Pancreas"},{"key":"2098_CR364","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1210\/jc.2018-01119","volume":"104","author":"Y Dong","year":"2019","unstructured":"Dong, Y. et al. Circulating adrenomedullin is elevated in gestational diabetes and its role in impaired insulin production by \u03b2-cells. J. Clin. Endocrinol. Metab. 104, 697\u2013706 (2019).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2098_CR365","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1038\/ajg.2010.32","volume":"105","author":"H Huang","year":"2010","unstructured":"Huang, H. et al. Novel blood biomarkers of pancreatic cancer-associated diabetes mellitus identified by peripheral blood-based gene expression profiles. Am. J. Gastroenterol. 105, 1661\u20131669 (2010).","journal-title":"Am. J. Gastroenterol."},{"key":"2098_CR366","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/JP9.0000000000000108","volume":"6","author":"C Qin","year":"2023","unstructured":"Qin, C. et al. Exosome-mediated cell\u2013cell communication within pancreatic cancer tumor microenvironment: a narrative review. J. Pancreatol. 6, 1 (2023).","journal-title":"J. Pancreatol."},{"key":"2098_CR367","doi-asserted-by":"publisher","first-page":"715043","DOI":"10.3389\/fendo.2021.715043","volume":"12","author":"E G\u00e1l","year":"2021","unstructured":"G\u00e1l, E. et al. Mechanisms of post-pancreatitis diabetes mellitus and cystic fibrosis-related diabetes: a review of preclinical studies. Front. Endocrinol. 12, 715043 (2021).","journal-title":"Front. Endocrinol."},{"key":"2098_CR368","doi-asserted-by":"publisher","first-page":"823","DOI":"10.2337\/dc17-1387","volume":"41","author":"RL Hull","year":"2018","unstructured":"Hull, R. L. et al. Islet interleukin-1\u03b2 immunoreactivity is an early feature of cystic fibrosis that may contribute to \u03b2-cell failure. Diabetes Care 41, 823\u2013830 (2018).","journal-title":"Diabetes Care"},{"key":"2098_CR369","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.98240","volume":"3","author":"NJ Hart","year":"2018","unstructured":"Hart, N. J. et al. Cystic fibrosis-related diabetes is caused by islet loss and inflammation. JCI Insight 3, e98240 (2018).","journal-title":"JCI Insight"},{"key":"2098_CR370","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1210\/en.2017-00187","volume":"158","author":"X Sun","year":"2017","unstructured":"Sun, X. et al. CFTR influences beta cell function and insulin secretion through non-cell autonomous exocrine-derived factors. Endocrinology 158, 3325\u20133338 (2017).","journal-title":"Endocrinology"},{"key":"2098_CR371","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1210\/jcem-69-2-317","volume":"69","author":"H Yki-J\u00e4rvinen","year":"1989","unstructured":"Yki-J\u00e4rvinen, H., Sammalkorpi, K., Koivisto, V. A. & Nikkil\u00e4, E. A. Severity, duration, and mechanisms of insulin resistance during acute infections. J. Clin. Endocrinol. Metab. 69, 317\u2013323 (1989).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2098_CR372","doi-asserted-by":"publisher","first-page":"119231","DOI":"10.1016\/j.lfs.2021.119231","volume":"286","author":"X Wu","year":"2021","unstructured":"Wu, X. et al. High-mobility group box protein-1 induces acute pancreatitis through activation of neutrophil extracellular trap and subsequent production of IL-1\u03b2. Life Sci. 286, 119231 (2021).","journal-title":"Life Sci."},{"key":"2098_CR373","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12929-016-0303-y","volume":"23","author":"K Rehman","year":"2016","unstructured":"Rehman, K. & Akash, M. S. H. Mechanisms of inflammatory responses and development of insulin resistance: how are they interlinked? J. Biomed. Sci. 23, 87 (2016).","journal-title":"J. Biomed. Sci."},{"key":"2098_CR374","doi-asserted-by":"publisher","first-page":"761","DOI":"10.3390\/cancers15030761","volume":"15","author":"G Le Cosquer","year":"2023","unstructured":"Le Cosquer, G. et al. Pancreatic cancer in chronic pancreatitis: pathogenesis and diagnostic approach. Cancers 15, 761 (2023).","journal-title":"Cancers"},{"key":"2098_CR375","doi-asserted-by":"publisher","first-page":"939","DOI":"10.2337\/db18-1138","volume":"68","author":"T Ang","year":"2019","unstructured":"Ang, T., Bruce, C. R. & Kowalski, G. M. Postprandial aminogenic insulin and glucagon secretion can stimulate glucose flux in humans. Diabetes 68, 939\u2013946 (2019).","journal-title":"Diabetes"},{"key":"2098_CR376","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1016\/j.cmet.2017.05.011","volume":"25","author":"ED Dean","year":"2017","unstructured":"Dean, E. D. et al. Interrupted glucagon signaling reveals hepatic \u03b1 cell axis and role for L-glutamine in \u03b1 cell proliferation. Cell Metab. 25, 1362\u20131373.e5 (2017).","journal-title":"Cell Metab."},{"key":"2098_CR377","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s00125-017-4535-5","volume":"61","author":"NJ Wewer Albrechtsen","year":"2018","unstructured":"Wewer Albrechtsen, N. J. et al. Evidence of a liver-alpha cell axis in humans: hepatic insulin resistance attenuates relationship between fasting plasma glucagon and glucagonotropic amino acids. Diabetologia 61, 671\u2013680 (2018).","journal-title":"Diabetologia"},{"key":"2098_CR378","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1210\/er.2018-00251","volume":"40","author":"NJ Wewer Albrechtsen","year":"2019","unstructured":"Wewer Albrechtsen, N. J. et al. The liver-\u03b1-cell axis and type 2 diabetes. Endocr. Rev. 40, 1353\u20131366 (2019).","journal-title":"Endocr. Rev."},{"key":"2098_CR379","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1097\/MPA.0b013e318194fc7a","volume":"38","author":"H Schrader","year":"2009","unstructured":"Schrader, H. et al. Amino acid malnutrition in patients with chronic pancreatitis and pancreatic carcinoma. Pancreas 38, 416\u2013421 (2009).","journal-title":"Pancreas"},{"key":"2098_CR380","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1097\/MPA.0000000000001077","volume":"47","author":"SJS Nagpal","year":"2018","unstructured":"Nagpal, S. J. S., Bamlet, W. R., Kudva, Y. C. & Chari, S. T. Comparison of fasting human pancreatic polypeptide levels among patients with pancreatic ductal adenocarcinoma, chronic pancreatitis, and type 2 diabetes mellitus. Pancreas 47, 738\u2013741 (2018).","journal-title":"Pancreas"},{"key":"2098_CR381","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0002-9610(99)80117-2","volume":"169","author":"NE Seymour","year":"1995","unstructured":"Seymour, N. E., Volpert, A. R., Lee, E. L., Andersen, D. K. & Hernandez, C. Alterations in hepatocyte insulin binding in chronic pancreatitis: effects of pancreatic polypeptide. Am. J. Surg. 169, 105\u2013110 (1995).","journal-title":"Am. J. Surg."},{"key":"2098_CR382","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/0022-4804(89)90159-5","volume":"46","author":"NE Seymour","year":"1989","unstructured":"Seymour, N. E. et al. In vitro hepatic insulin resistance in chronic pancreatitis in the rat. J. Surg. Res. 46, 450\u2013456 (1989).","journal-title":"J. Surg. Res."},{"key":"2098_CR383","first-page":"3566","volume":"81","author":"FC Brunicardi","year":"1996","unstructured":"Brunicardi, F. C. et al. Pancreatic polypeptide administration improves abnormal glucose metabolism in patients with chronic pancreatitis. J. Clin. Endocrinol. Metab. 81, 3566\u20133572 (1996).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2098_CR384","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-12-87","volume":"12","author":"A Edlund","year":"2014","unstructured":"Edlund, A., Esguerra, J. L. S., Wendt, A., Flodstr\u00f6m-Tullberg, M. & Eliasson, L. CFTR and anoctamin 1 (ANO1) contribute to cAMP amplified exocytosis and insulin secretion in human and murine pancreatic beta-cells. BMC Med. 12, 87 (2014).","journal-title":"BMC Med."},{"key":"2098_CR385","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5420","volume":"5","author":"JH Guo","year":"2014","unstructured":"Guo, J. H. et al. Glucose-induced electrical activities and insulin secretion in pancreatic islet \u03b2-cells are modulated by CFTR. Nat. Commun. 5, 4420 (2014).","journal-title":"Nat. Commun."},{"key":"2098_CR386","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.jcf.2017.11.016","volume":"17","author":"JC Thomassen","year":"2018","unstructured":"Thomassen, J. C., Mueller, M. I., Alejandre Alcazar, M. A., Rietschel, E. & van Koningsbruggen-Rietschel, S. Effect of lumacaftor\/ivacaftor on glucose metabolism and insulin secretion in Phe508del homozygous cystic fibrosis patients. J. Cyst. Fibros. 17, 271\u2013275 (2018).","journal-title":"J. Cyst. Fibros."},{"key":"2098_CR387","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s12020-007-9026-x","volume":"32","author":"A Boom","year":"2007","unstructured":"Boom, A. et al. Expression and localization of cystic fibrosis transmembrane conductance regulator in the rat endocrine pancreas. Endocrine 32, 197\u2013205 (2007).","journal-title":"Endocrine"},{"key":"2098_CR388","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1530\/JOE-18-0570","volume":"241","author":"A Edlund","year":"2019","unstructured":"Edlund, A. et al. Defective exocytosis and processing of insulin in a cystic fibrosis mouse model. J. Endocrinol. 241, 45\u201357 (2019).","journal-title":"J. Endocrinol."},{"key":"2098_CR389","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1210\/clinem\/dgz209","volume":"105","author":"MG White","year":"2020","unstructured":"White, M. G. et al. In situ analysis reveals that CFTR is expressed in only a small minority of \u03b2-cells in normal adult human pancreas. J. Clin. Endocrinol. Metab. 105, 1366\u20131374 (2020).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2098_CR390","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/0168-8227(92)90068-3","volume":"15","author":"H Tabata","year":"1992","unstructured":"Tabata, H. et al. Islet amyloid polypeptide (IAPP\/amylin) causes insulin resistance in perfused rat hindlimb muscle. Diabetes Res. Clin. Pract. 15, 57\u201361 (1992).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"2098_CR391","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1056\/NEJM199402033300503","volume":"330","author":"J Permert","year":"1994","unstructured":"Permert, J. et al. Islet amyloid polypeptide in patients with pancreatic cancer and diabetes. N. Engl. J. Med. 330, 313\u2013318 (1994).","journal-title":"N. Engl. J. Med."},{"key":"2098_CR392","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1097\/00006676-199905000-00012","volume":"18","author":"F Wang","year":"1999","unstructured":"Wang, F., Adrian, T. E., Westermark, G., Gasslander, T. & Permert, J. Dissociated insulin and islet amyloid polypeptide secretion from isolated rat pancreatic islets cocultured with human pancreatic adenocarcinoma cells. Pancreas 18, 403\u2013409 (1999).","journal-title":"Pancreas"},{"key":"2098_CR393","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/S0016-5085(98)70641-9","volume":"114","author":"X Ding","year":"1998","unstructured":"Ding, X., Flatt, P. R., Permert, J. & Adrian, T. E. Pancreatic cancer cells selectively stimulate islet beta cells to secrete amylin. Gastroenterology 114, 130\u2013138 (1998).","journal-title":"Gastroenterology"},{"key":"2098_CR394","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1053\/gast.2001.27210","volume":"121","author":"ST Chari","year":"2001","unstructured":"Chari, S. T., Klee, G. G., Miller, L. J., Raimondo, M. & DiMagno, E. P. Islet amyloid polypeptide is not a satisfactory marker for detecting pancreatic cancer. Gastroenterology 121, 640\u2013645 (2001).","journal-title":"Gastroenterology"},{"key":"2098_CR395","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.cca.2006.03.027","volume":"372","author":"D Basso","year":"2006","unstructured":"Basso, D. et al. Pancreatic cancer-derived S-100A8 N-terminal peptide: a diabetes cause? Clin. Chim. Acta 372, 120\u2013128 (2006).","journal-title":"Clin. Chim. Acta"},{"key":"2098_CR396","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.cccn.2005.03.025","volume":"357","author":"D Basso","year":"2005","unstructured":"Basso, D. et al. Pancreatic cancer-associated diabetes mellitus: an open field for proteomic applications. Clin. Chim. Acta 357, 184\u2013189 (2005).","journal-title":"Clin. Chim. Acta"},{"key":"2098_CR397","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1126\/science.7678183","volume":"259","author":"GS Hotamisligil","year":"1993","unstructured":"Hotamisligil, G. S., Shargill, N. S. & Spiegelman, B. M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259, 87\u201391 (1993).","journal-title":"Science"},{"key":"2098_CR398","doi-asserted-by":"publisher","first-page":"e51768","DOI":"10.1371\/journal.pone.0051768","volume":"7","author":"P Marques-Vidal","year":"2012","unstructured":"Marques-Vidal, P. et al. Adipocytokines, hepatic and inflammatory biomarkers and incidence of type 2 diabetes. the CoLaus study. PLoS ONE 7, e51768 (2012).","journal-title":"PLoS ONE"},{"key":"2098_CR399","first-page":"1245","volume":"70","author":"N Matulewicz","year":"2016","unstructured":"Matulewicz, N. & Karczewska-Kupczewska, M. Insulin resistance and chronic inflammation. Postepy Hig. Med. Dosw. 70, 1245\u20131258 (2016).","journal-title":"Postepy Hig. Med. Dosw."},{"key":"2098_CR400","doi-asserted-by":"publisher","first-page":"S161","DOI":"10.2337\/dc08-s243","volume":"31","author":"MY Donath","year":"2008","unstructured":"Donath, M. Y. et al. Islet inflammation in type 2 diabetes: from metabolic stress to therapy. Diabetes Care 31 (Suppl. 2), S161\u2013S164 (2008).","journal-title":"Diabetes Care"},{"key":"2098_CR401","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1001\/jama.298.17.2028","volume":"298","author":"KM Flegal","year":"2007","unstructured":"Flegal, K. M., Graubard, B. I., Williamson, D. F. & Gail, M. H. Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA 298, 2028\u20132037 (2007).","journal-title":"JAMA"},{"key":"2098_CR402","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1056\/NEJMoa010492","volume":"345","author":"FB Hu","year":"2001","unstructured":"Hu, F. B. et al. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N. Engl. J. Med. 345, 790\u2013797 (2001).","journal-title":"N. Engl. J. Med."},{"key":"2098_CR403","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1001\/jama.282.16.1523","volume":"282","author":"A Must","year":"1999","unstructured":"Must, A. et al. The disease burden associated with overweight and obesity. JAMA 282, 1523\u20131529 (1999).","journal-title":"JAMA"},{"key":"2098_CR404","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/S2213-8587(19)30084-1","volume":"7","author":"IJ Neeland","year":"2019","unstructured":"Neeland, I. J. et al. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. Lancet Diabetes Endocrinol. 7, 715\u2013725 (2019).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"2098_CR405","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.metabol.2018.11.001","volume":"92","author":"KI Avgerinos","year":"2019","unstructured":"Avgerinos, K. I., Spyrou, N., Mantzoros, C. S. & Dalamaga, M. Obesity and cancer risk: Emerging biological mechanisms and perspectives. Metabolism 92, 121\u2013135 (2019).","journal-title":"Metabolism"},{"key":"2098_CR406","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1002\/ijc.25794","volume":"129","author":"JM Genkinger","year":"2011","unstructured":"Genkinger, J. M. et al. A pooled analysis of 14 cohort studies of anthropometric factors and pancreatic cancer risk. Int. J. Cancer 129, 1708\u20131717 (2011).","journal-title":"Int. J. Cancer"},{"key":"2098_CR407","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1158\/2159-8290.CD-15-1177","volume":"6","author":"J Incio","year":"2016","unstructured":"Incio, J. et al. Obesity-induced inflammation and desmoplasia promote pancreatic cancer progression and resistance to chemotherapy. Cancer Discov. 6, 852\u2013869 (2016).","journal-title":"Cancer Discov."},{"key":"2098_CR408","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/prca.201100052","volume":"6","author":"S Lehr","year":"2012","unstructured":"Lehr, S., Hartwig, S. & Sell, H. Adipokines: a treasure trove for the discovery of biomarkers for metabolic disorders. Proteom. Clin. Appl. 6, 91\u2013101 (2012).","journal-title":"Proteom. Clin. Appl."},{"key":"2098_CR409","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.semcancer.2023.11.002","volume":"97","author":"M Srilatha","year":"2023","unstructured":"Srilatha, M., Malla, R., Adem, M. P., Foote, J. B. & Nagaraju, G. P. Obesity associated pancreatic ductal adenocarcinoma: therapeutic challenges. Semin. Cancer Biol. 97, 12\u201320 (2023).","journal-title":"Semin. Cancer Biol."},{"key":"2098_CR410","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.febslet.2004.11.024","volume":"579","author":"M Otero","year":"2005","unstructured":"Otero, M. et al. Leptin, from fat to inflammation: old questions and new insights. FEBS Lett. 579, 295\u2013301 (2005).","journal-title":"FEBS Lett."},{"key":"2098_CR411","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.4161\/cc.7.12.6157","volume":"7","author":"CM Maya-Monteiro","year":"2008","unstructured":"Maya-Monteiro, C. M. & Bozza, P. T. Leptin and mTOR: partners in metabolism and inflammation. Cell Cycle Georget. Tex. 7, 1713\u20131717 (2008).","journal-title":"Cell Cycle Georget. Tex."},{"key":"2098_CR412","first-page":"945","volume":"21","author":"Y Xu","year":"2020","unstructured":"Xu, Y. et al. Leptin receptor mediates the proliferation and glucose metabolism of pancreatic cancer cells via AKT pathway activation. Mol. Med. Rep. 21, 945\u2013952 (2020).","journal-title":"Mol. Med. Rep."},{"key":"2098_CR413","doi-asserted-by":"publisher","first-page":"16120","DOI":"10.18632\/oncotarget.3878","volume":"6","author":"Y Fan","year":"2015","unstructured":"Fan, Y. et al. Leptin signaling enhances cell invasion and promotes the metastasis of human pancreatic cancer via increasing MMP-13 production. Oncotarget 6, 16120\u201316134 (2015).","journal-title":"Oncotarget"},{"key":"2098_CR414","doi-asserted-by":"publisher","first-page":"26746","DOI":"10.1074\/jbc.270.45.26746","volume":"270","author":"PE Scherer","year":"1995","unstructured":"Scherer, P. E., Williams, S., Fogliano, M., Baldini, G. & Lodish, H. F. A novel serum protein similar to C1q, produced exclusively in adipocytes. J. Biol. Chem. 270, 26746\u201326749 (1995).","journal-title":"J. Biol. Chem."},{"key":"2098_CR415","doi-asserted-by":"publisher","first-page":"10697","DOI":"10.1074\/jbc.271.18.10697","volume":"271","author":"E Hu","year":"1996","unstructured":"Hu, E., Liang, P. & Spiegelman, B. M. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J. Biol. Chem. 271, 10697\u201310703 (1996).","journal-title":"J. Biol. Chem."},{"key":"2098_CR416","doi-asserted-by":"publisher","first-page":"4732","DOI":"10.18632\/oncotarget.1963","volume":"5","author":"B Huang","year":"2014","unstructured":"Huang, B. et al. Adiponectin promotes pancreatic cancer progression by inhibiting apoptosis via the activation of AMPK\/Sirt1\/PGC-1\u03b1 signaling. Oncotarget 5, 4732\u20134745 (2014).","journal-title":"Oncotarget"},{"key":"2098_CR417","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1053\/j.gastro.2009.04.013","volume":"137","author":"D Li","year":"2009","unstructured":"Li, D., Yeung, S.-C. J., Hassan, M. M., Konopleva, M. & Abbruzzese, J. L. Antidiabetic therapies affect risk of pancreatic cancer. Gastroenterology 137, 482\u2013488 (2009).","journal-title":"Gastroenterology"},{"key":"2098_CR418","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1158\/1078-0432.CCR-11-2994","volume":"18","author":"N Sadeghi","year":"2012","unstructured":"Sadeghi, N., Abbruzzese, J. L., Yeung, S.-C. J., Hassan, M. & Li, D. Metformin use is associated with better survival of diabetic patients with pancreatic cancer. Clin. Cancer Res. 18, 2905\u20132912 (2012).","journal-title":"Clin. Cancer Res."},{"key":"2098_CR419","doi-asserted-by":"publisher","first-page":"6539","DOI":"10.1158\/0008-5472.CAN-09-0418","volume":"69","author":"K Kisfalvi","year":"2009","unstructured":"Kisfalvi, K., Eibl, G., Sinnett-Smith, J. & Rozengurt, E. Metformin disrupts crosstalk between G protein-coupled receptor and insulin receptor signaling systems and inhibits pancreatic cancer growth. Cancer Res. 69, 6539\u20136545 (2009).","journal-title":"Cancer Res."},{"key":"2098_CR420","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1097\/MPA.0b013e31827aec40","volume":"42","author":"K Kisfalvi","year":"2013","unstructured":"Kisfalvi, K., Moro, A., Sinnett-Smith, J., Eibl, G. & Rozengurt, E. Metformin inhibits the growth of human pancreatic cancer xenografts. Pancreas 42, 781\u2013785 (2013).","journal-title":"Pancreas"},{"key":"2098_CR421","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1097\/MPA.0000000000000308","volume":"44","author":"X-L Tan","year":"2015","unstructured":"Tan, X.-L. et al. Metformin suppresses pancreatic tumor growth with inhibition of NF\u03baB\/STAT3 inflammatory signaling. Pancreas 44, 636\u2013647 (2015).","journal-title":"Pancreas"},{"key":"2098_CR422","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-017-0701-0","volume":"16","author":"K Chen","year":"2017","unstructured":"Chen, K. et al. Metformin suppresses cancer initiation and progression in genetic mouse models of pancreatic cancer. Mol. Cancer 16, 131 (2017).","journal-title":"Mol. Cancer"},{"key":"2098_CR423","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-24337-8","volume":"8","author":"H-H Chang","year":"2018","unstructured":"Chang, H.-H. et al. Metformin decreases the incidence of pancreatic ductal adenocarcinoma promoted by diet-induced obesity in the conditional KrasG12D mouse model. Sci. Rep. 8, 5899 (2018).","journal-title":"Sci. Rep."},{"key":"2098_CR424","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s10555-021-09977-z","volume":"40","author":"G Eibl","year":"2021","unstructured":"Eibl, G. & Rozengurt, E. Metformin: review of epidemiology and mechanisms of action in pancreatic cancer. Cancer Metastasis Rev. 40, 865\u2013878 (2021).","journal-title":"Cancer Metastasis Rev."},{"key":"2098_CR425","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.84532","volume":"13","author":"Y Wu","year":"2024","unstructured":"Wu, Y. et al. Hippo pathway-mediated YAP1\/TAZ inhibition is essential for proper pancreatic endocrine specification and differentiation. eLife 13, e84532 (2024).","journal-title":"eLife"},{"key":"2098_CR426","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/s13238-020-00760-4","volume":"12","author":"C Wang","year":"2021","unstructured":"Wang, C. et al. Metformin inhibits pancreatic cancer metastasis caused by SMAD4 deficiency and consequent HNF4G upregulation. Protein Cell 12, 128\u2013144 (2021).","journal-title":"Protein Cell"},{"key":"2098_CR427","doi-asserted-by":"publisher","first-page":"e21368","DOI":"10.1371\/journal.pone.0021368","volume":"6","author":"C-H Chang","year":"2011","unstructured":"Chang, C.-H. et al. Cancer risk associated with insulin glargine among adult type 2 diabetes patients-a nationwide cohort study. PLoS ONE 6, e21368 (2011).","journal-title":"PLoS ONE"},{"key":"2098_CR428","doi-asserted-by":"publisher","first-page":"333","DOI":"10.2174\/15680266113136660067","volume":"8","author":"O Karlstad","year":"2013","unstructured":"Karlstad, O. et al. Use of insulin and insulin analogs and risk of cancer - systematic review and meta-analysis of observational studies. Curr. Drug Saf. 8, 333\u2013348 (2013).","journal-title":"Curr. Drug Saf."},{"key":"2098_CR429","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1055\/s-2007-957352","volume":"39","author":"K Staiger","year":"2007","unstructured":"Staiger, K., Hennige, A. M., Staiger, H., H\u00e4ring, H.-U. & Kellerer, M. Comparison of the mitogenic potency of regular human insulin and its analogue glargine in normal and transformed human breast epithelial cells. Horm. Metab. Res. 39, 65\u201367 (2007).","journal-title":"Horm. Metab. Res."},{"key":"2098_CR430","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.tem.2020.05.004","volume":"31","author":"R Vigneri","year":"2020","unstructured":"Vigneri, R., Sciacca, L. & Vigneri, P. Rethinking the relationship between insulin and cancer. Trends Endocrinol. Metab. 31, 551\u2013560 (2020).","journal-title":"Trends Endocrinol. Metab."},{"key":"2098_CR431","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1677\/ERC-08-0240","volume":"16","author":"A Shukla","year":"2009","unstructured":"Shukla, A. et al. Analysis of signaling pathways related to cell proliferation stimulated by insulin analogs in human mammary epithelial cell lines. Endocr. Relat. Cancer 16, 429\u2013441 (2009).","journal-title":"Endocr. Relat. Cancer"},{"key":"2098_CR432","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.4251\/wjgo.v13.i11.1709","volume":"13","author":"B-W Teng","year":"2021","unstructured":"Teng, B.-W. et al. Genome-wide CRISPR-Cas9 screening identifies that hypoxia-inducible factor-1a-induced CBX8 transcription promotes pancreatic cancer progression via IRS1\/AKT axis. World J. Gastrointest. Oncol. 13, 1709\u20131724 (2021).","journal-title":"World J. Gastrointest. Oncol."},{"key":"2098_CR433","doi-asserted-by":"publisher","first-page":"1116582","DOI":"10.3389\/fendo.2023.1116582","volume":"14","author":"L Zhong","year":"2023","unstructured":"Zhong, L., Liu, J., Liu, S. & Tan, G. Correlation between pancreatic cancer and metabolic syndrome: a systematic review and meta-analysis. Front. Endocrinol. 14, 1116582 (2023).","journal-title":"Front. Endocrinol."},{"key":"2098_CR434","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s11010-010-0617-0","volume":"347","author":"H Liu","year":"2011","unstructured":"Liu, H., Ma, Q. & Li, J. High glucose promotes cell proliferation and enhances GDNF and RET expression in pancreatic cancer cells. Mol. Cell. Biochem. 347, 95\u2013101 (2011).","journal-title":"Mol. Cell. Biochem."},{"key":"2098_CR435","doi-asserted-by":"publisher","first-page":"940","DOI":"10.2174\/138161208784139765","volume":"14","author":"R Abe","year":"2008","unstructured":"Abe, R. & Yamagishi, S. AGE-RAGE system and carcinogenesis. Curr. Pharm. Des. 14, 940\u2013945 (2008).","journal-title":"Curr. Pharm. Des."},{"key":"2098_CR436","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s11605-011-1754-9","volume":"16","author":"J DiNorcia","year":"2012","unstructured":"DiNorcia, J. et al. RAGE gene deletion inhibits the development and progression of ductal neoplasia and prolongs survival in a murine model of pancreatic cancer. J. Gastrointest. Surg. 16, 104\u2013112 (2012).","journal-title":"J. Gastrointest. Surg."},{"key":"2098_CR437","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41568-020-0295-5","volume":"20","author":"EJ Gallagher","year":"2020","unstructured":"Gallagher, E. J. & LeRoith, D. Hyperinsulinaemia in cancer. Nat. Rev. Cancer 20, 629\u2013644 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"2098_CR438","doi-asserted-by":"publisher","first-page":"862","DOI":"10.3945\/ajcn.110.011205","volume":"94","author":"Y Bao","year":"2011","unstructured":"Bao, Y. et al. Dietary insulin load, dietary insulin index, and risk of pancreatic cancer. Am. J. Clin. Nutr. 94, 862\u2013868 (2011).","journal-title":"Am. J. Clin. Nutr."},{"key":"2098_CR439","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00125-009-1556-8","volume":"53","author":"AE Butler","year":"2010","unstructured":"Butler, A. E. et al. Pancreatic duct replication is increased with obesity and type 2 diabetes in humans. Diabetologia 53, 21\u201326 (2010).","journal-title":"Diabetologia"},{"key":"2098_CR440","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1054\/mehy.2001.1316","volume":"57","author":"MF McCarty","year":"2001","unstructured":"McCarty, M. F. Insulin secretion as a determinant of pancreatic cancer risk. Med. Hypotheses 57, 146\u2013150 (2001).","journal-title":"Med. Hypotheses"},{"key":"2098_CR441","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1007\/s11605-010-1349-x","volume":"14","author":"PB White","year":"2010","unstructured":"White, P. B. et al. Insulin, leptin, and tumoral adipocytes promote murine pancreatic cancer growth. J. Gastrointest. Surg. 14, 1888\u20131894 (2010).","journal-title":"J. Gastrointest. Surg."},{"key":"2098_CR442","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.cmet.2019.07.003","volume":"30","author":"AMY Zhang","year":"2019","unstructured":"Zhang, A. M. Y. et al. Endogenous hyperinsulinemia contributes to pancreatic cancer development. Cell Metab. 30, 403\u2013404 (2019).","journal-title":"Cell Metab."},{"key":"2098_CR443","doi-asserted-by":"publisher","first-page":"R67","DOI":"10.1530\/JME-12-0259","volume":"50","author":"M Trajkovic-Arsic","year":"2013","unstructured":"Trajkovic-Arsic, M., Kalideris, E. & Siveke, J. T. The role of insulin and IGF system in pancreatic cancer. J. Mol. Endocrinol. 50, R67\u2013R74 (2013).","journal-title":"J. Mol. Endocrinol."},{"key":"2098_CR444","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1006\/jsre.1996.0266","volume":"63","author":"WE Fisher","year":"1996","unstructured":"Fisher, W. E., Boros, L. G. & Schirmer, W. J. Insulin promotes pancreatic cancer: evidence for endocrine influence on exocrine pancreatic tumors. J. Surg. Res. 63, 310\u2013313 (1996).","journal-title":"J. Surg. Res."},{"key":"2098_CR445","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-814","volume":"14","author":"MT Chan","year":"2014","unstructured":"Chan, M. T. et al. Effects of insulin on human pancreatic cancer progression modeled in vitro. BMC Cancer 14, 814 (2014).","journal-title":"BMC Cancer"},{"key":"2098_CR446","doi-asserted-by":"publisher","first-page":"G675","DOI":"10.1152\/ajpgi.00251.2016","volume":"311","author":"J Yang","year":"2016","unstructured":"Yang, J. et al. Insulin promotes proliferation and fibrosing responses in activated pancreatic stellate cells. Am. J. Physiol. Gastrointest. Liver Physiol. 311, G675\u2013G687 (2016).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"2098_CR447","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1006\/bbrc.1996.0500","volume":"220","author":"U Bergmann","year":"1996","unstructured":"Bergmann, U., Funatomi, H., Kornmann, M., Beger, H. G. & Korc, M. Increased expression of insulin receptor substrate-1 in human pancreatic cancer. Biochem. Biophys. Res. Commun. 220, 886\u2013890 (1996).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2098_CR448","first-page":"4250","volume":"58","author":"M Kornmann","year":"1998","unstructured":"Kornmann, M. et al. Enhanced expression of the insulin receptor substrate-2 docking protein in human pancreatic cancer. Cancer Res. 58, 4250\u20134254 (1998).","journal-title":"Cancer Res."},{"key":"2098_CR449","doi-asserted-by":"publisher","first-page":"9164","DOI":"10.1158\/0008-5472.CAN-05-0779","volume":"65","author":"T Asano","year":"2005","unstructured":"Asano, T. et al. Insulin receptor substrate is a mediator of phosphoinositide 3-kinase activation in quiescent pancreatic cancer cells. Cancer Res. 65, 9164\u20139168 (2005).","journal-title":"Cancer Res."},{"key":"2098_CR450","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1158\/1078-0432.CCR-09-2229","volume":"16","author":"E Rozengurt","year":"2010","unstructured":"Rozengurt, E., Sinnett-Smith, J. & Kisfalvi, K. Crosstalk between insulin\/insulin-like growth factor-1 receptors and G protein-coupled receptor signaling systems: a novel target for the antidiabetic drug metformin in pancreatic cancer. Clin. Cancer Res. 16, 2505\u20132511 (2010).","journal-title":"Clin. Cancer Res."},{"key":"2098_CR451","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1158\/1541-7786.MCR-17-0023","volume":"15","author":"F Hao","year":"2017","unstructured":"Hao, F. et al. Insulin receptor and GPCR crosstalk stimulates YAP via PI3K and PKD in pancreatic cancer cells. Mol. Cancer Res. 15, 929\u2013941 (2017).","journal-title":"Mol. Cancer Res."},{"key":"2098_CR452","doi-asserted-by":"publisher","first-page":"7706","DOI":"10.1111\/jcmm.15413","volume":"24","author":"B Quoc Lam","year":"2020","unstructured":"Quoc Lam, B., Shrivastava, S. K., Shrivastava, A., Shankar, S. & Srivastava, R. K. The Impact of obesity and diabetes mellitus on pancreatic cancer: Molecular mechanisms and clinical perspectives. J. Cell. Mol. Med. 24, 7706\u20137716 (2020).","journal-title":"J. Cell. Mol. Med."},{"key":"2098_CR453","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.beem.2008.08.004","volume":"22","author":"M Pollak","year":"2008","unstructured":"Pollak, M. Insulin, insulin-like growth factors and neoplasia. Best. Pract. Res. Clin. Endocrinol. Metab. 22, 625\u2013638 (2008).","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"key":"2098_CR454","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1093\/jnci\/92.18.1472","volume":"92","author":"H Yu","year":"2000","unstructured":"Yu, H. & Rohan, T. Role of the insulin-like growth factor family in cancer development and progression. J. Natl Cancer Inst. 92, 1472\u20131489 (2000).","journal-title":"J. Natl Cancer Inst."},{"key":"2098_CR455","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1023\/A:1026122421369","volume":"48","author":"A Hakam","year":"2003","unstructured":"Hakam, A., Fang, Q., Karl, R. & Coppola, D. Coexpression of IGF-1R and c-Src proteins in human pancreatic ductal adenocarcinoma. Dig. Dis. Sci. 48, 1972\u20131978 (2003).","journal-title":"Dig. Dis. Sci."},{"key":"2098_CR456","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1002\/cncr.26661","volume":"118","author":"ME Valsecchi","year":"2012","unstructured":"Valsecchi, M. E. et al. Epidermal growth factor receptor and insulinlike growth factor 1 receptor expression predict poor survival in pancreatic ductal adenocarcinoma. Cancer 118, 3484\u20133493 (2012).","journal-title":"Cancer"},{"key":"2098_CR457","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1158\/1541-7786.MCR-12-0340-T","volume":"10","author":"VA Appleman","year":"2012","unstructured":"Appleman, V. A., Ahronian, L. G., Cai, J., Klimstra, D. S. & Lewis, B. C. KRAS(G12D)- and BRAF(V600E)-induced transformation of murine pancreatic epithelial cells requires MEK\/ERK-stimulated IGF1R signaling. Mol. Cancer Res. 10, 1228\u20131239 (2012).","journal-title":"Mol. Cancer Res."},{"key":"2098_CR458","first-page":"2007","volume":"55","author":"U Bergmann","year":"1995","unstructured":"Bergmann, U., Funatomi, H., Yokoyama, M., Beger, H. G. & Korc, M. Insulin-like growth factor I overexpression in human pancreatic cancer: evidence for autocrine and paracrine roles. Cancer Res. 55, 2007\u20132011 (1995).","journal-title":"Cancer Res."},{"key":"2098_CR459","doi-asserted-by":"publisher","first-page":"427","DOI":"10.2174\/187152011795677454","volume":"11","author":"S Rieder","year":"2011","unstructured":"Rieder, S., Michalski, C. W., Friess, H. & Kleeff, J. Insulin-like growth factor signaling as a therapeutic target in pancreatic cancer. Anticancer Agents Med. Chem. 11, 427\u2013433 (2011).","journal-title":"Anticancer Agents Med. Chem."},{"key":"2098_CR460","doi-asserted-by":"publisher","first-page":"3278","DOI":"10.1128\/MCB.19.5.3278","volume":"19","author":"F Frasca","year":"1999","unstructured":"Frasca, F. et al. Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells. Mol. Cell. Biol. 19, 3278\u20133288 (1999).","journal-title":"Mol. Cell. Biol."},{"key":"2098_CR461","doi-asserted-by":"publisher","first-page":"156","DOI":"10.2165\/00003495-198733020-00004","volume":"33","author":"GM Ward","year":"1987","unstructured":"Ward, G. M. The insulin receptor concept and its relation to the treatment of diabetes. Drugs 33, 156\u2013170 (1987).","journal-title":"Drugs"},{"key":"2098_CR462","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1056\/NEJM197604012941401","volume":"294","author":"CR Kahn","year":"1976","unstructured":"Kahn, C. R. et al. The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man. N. Engl. J. Med. 294, 739\u2013745 (1976).","journal-title":"N. Engl. J. Med."},{"key":"2098_CR463","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1210\/edrv-13-3-566","volume":"13","author":"SI Taylor","year":"1992","unstructured":"Taylor, S. I. et al. Mutations in the insulin receptor gene. Endocr. Rev. 13, 566\u2013595 (1992).","journal-title":"Endocr. Rev."},{"key":"2098_CR464","doi-asserted-by":"publisher","first-page":"E413","DOI":"10.1152\/ajpendo.00514.2001","volume":"283","author":"MF White","year":"2002","unstructured":"White, M. F. IRS proteins and the common path to diabetes. Am. J. Physiol. Endocrinol. Metab. 283, E413\u2013E422 (2002).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"2098_CR465","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1111\/j.1582-4934.2008.00246.x","volume":"12","author":"ML Hribal","year":"2008","unstructured":"Hribal, M. L. et al. Transgenic mice overexpressing human G972R IRS-1 show impaired insulin action and insulin secretion. J. Cell. Mol. Med. 12, 2096\u20132106 (2008).","journal-title":"J. Cell. Mol. Med."},{"key":"2098_CR466","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1111\/j.1469-1809.2011.00668.x","volume":"75","author":"LE Mart\u00ednez-G\u00f3mez","year":"2011","unstructured":"Mart\u00ednez-G\u00f3mez, L. E. et al. A replication study of the IRS1, CAPN10, TCF7L2, and PPARG gene polymorphisms associated with type 2 diabetes in two different populations of Mexico. Ann. Hum. Genet. 75, 612\u2013620 (2011).","journal-title":"Ann. Hum. Genet."},{"key":"2098_CR467","doi-asserted-by":"publisher","first-page":"123","DOI":"10.14348\/molcells.2017.2228","volume":"40","author":"C-Y Tang","year":"2017","unstructured":"Tang, C.-Y. et al. IRS-2 partially compensates for the insulin signal defects in IRS-1-\/- mice mediated by miR-33. Mol. Cells 40, 123\u2013132 (2017).","journal-title":"Mol. Cells"},{"key":"2098_CR468","doi-asserted-by":"publisher","first-page":"a009191","DOI":"10.1101\/cshperspect.a009191","volume":"6","author":"J Boucher","year":"2014","unstructured":"Boucher, J., Kleinridders, A. & Kahn, C. R. Insulin receptor signaling in normal and insulin-resistant states. Cold Spring Harb. Perspect. Biol. 6, a009191 (2014).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"2098_CR469","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1126\/science.1096706","volume":"304","author":"S George","year":"2004","unstructured":"George, S. et al. A family with severe insulin resistance and diabetes mellitus due to a missense mutation in AKT2. Science 304, 1325\u20131328 (2004).","journal-title":"Science"},{"key":"2098_CR470","doi-asserted-by":"publisher","first-page":"714","DOI":"10.2337\/db06-0921","volume":"56","author":"K Tan","year":"2007","unstructured":"Tan, K. et al. Analysis of genetic variation in Akt2\/PKB-\u03b2 in severe insulin resistance, lipodystrophy, type 2 diabetes, and related metabolic phenotypes. Diabetes 56, 714\u2013719 (2007).","journal-title":"Diabetes"},{"key":"2098_CR471","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.cell.2017.04.001","volume":"169","author":"BD Manning","year":"2017","unstructured":"Manning, B. D. & Toker, A. AKT\/PKB signaling: navigating the network. Cell 169, 381\u2013405 (2017).","journal-title":"Cell"},{"key":"2098_CR472","doi-asserted-by":"publisher","first-page":"5009","DOI":"10.1128\/MCB.00797-10","volume":"30","author":"SM Choi","year":"2010","unstructured":"Choi, S. M. et al. Insulin regulates adipocyte lipolysis via an Akt-independent signaling pathway. Mol. Cell. Biol. 30, 5009\u20135020 (2010).","journal-title":"Mol. Cell. Biol."},{"key":"2098_CR473","doi-asserted-by":"publisher","first-page":"973","DOI":"10.2337\/diabetes.47.6.973","volume":"47","author":"LJ Baier","year":"1998","unstructured":"Baier, L. J., Wiedrich, C., Hanson, R. L. & Bogardus, C. Variant in the regulatory subunit of phosphatidylinositol 3-kinase (p85alpha): preliminary evidence indicates a potential role of this variant in the acute insulin response and type 2 diabetes in Pima women. Diabetes 47, 973\u2013975 (1998).","journal-title":"Diabetes"},{"key":"2098_CR474","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1073\/pnas.042688799","volume":"99","author":"K Almind","year":"2002","unstructured":"Almind, K. et al. Characterization of the Met326Ile variant of phosphatidylinositol 3-kinase p85\u03b1. Proc. Natl Acad. Sci. USA 99, 2124\u20132128 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2098_CR475","doi-asserted-by":"publisher","first-page":"e79","DOI":"10.1097\/MJT.0000000000001088","volume":"27","author":"P Aschner","year":"2020","unstructured":"Aschner, P. Insulin therapy in type 2 diabetes. Am. J. Ther. 27, e79\u2013e90 (2020).","journal-title":"Am. J. Ther."},{"key":"2098_CR476","first-page":"E108","volume":"257","author":"DH Wasserman","year":"1989","unstructured":"Wasserman, D. H. et al. Glucagon is a primary controller of hepatic glycogenolysis and gluconeogenesis during muscular work. Am. J. Physiol. 257, E108\u2013E117 (1989).","journal-title":"Am. J. Physiol."},{"key":"2098_CR477","doi-asserted-by":"publisher","first-page":"928016","DOI":"10.3389\/fendo.2022.928016","volume":"13","author":"Y Jia","year":"2022","unstructured":"Jia, Y., Liu, Y., Feng, L., Sun, S. & Sun, G. Role of glucagon and its receptor in the pathogenesis of diabetes. Front. Endocrinol. 13, 928016 (2022).","journal-title":"Front. Endocrinol."},{"key":"2098_CR478","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s00125-006-0481-3","volume":"50","author":"SL Conarello","year":"2007","unstructured":"Conarello, S. L. et al. Glucagon receptor knockout mice are resistant to diet-induced obesity and streptozotocin-mediated beta cell loss and hyperglycaemia. Diabetologia 50, 142\u2013150 (2007).","journal-title":"Diabetologia"},{"key":"2098_CR479","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1172\/JCI60016","volume":"122","author":"RH Unger","year":"2012","unstructured":"Unger, R. H. & Cherrington, A. D. Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover. J. Clin. Invest. 122, 4\u201312 (2012).","journal-title":"J. Clin. Invest."},{"key":"2098_CR480","doi-asserted-by":"publisher","first-page":"391","DOI":"10.2337\/db10-0426","volume":"60","author":"Y Lee","year":"2011","unstructured":"Lee, Y., Wang, M.-Y., Du, X. Q., Charron, M. J. & Unger, R. H. Glucagon receptor knockout prevents insulin-deficient type 1 diabetes in mice. Diabetes 60, 391\u2013397 (2011).","journal-title":"Diabetes"},{"key":"2098_CR481","doi-asserted-by":"publisher","first-page":"14972","DOI":"10.1073\/pnas.1205983109","volume":"109","author":"Y Lee","year":"2012","unstructured":"Lee, Y. et al. Metabolic manifestations of insulin deficiency do not occur without glucagon action. Proc. Natl Acad. Sci. USA 109, 14972\u201314976 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2098_CR482","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1073\/pnas.0237106100","volume":"100","author":"RW Gelling","year":"2003","unstructured":"Gelling, R. W. et al. Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice. Proc. Natl Acad. Sci. USA 100, 1438\u20131443 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2098_CR483","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nature04410","volume":"439","author":"O Dyachok","year":"2006","unstructured":"Dyachok, O., Isakov, Y., S\u00e5getorp, J. & Tengholm, A. Oscillations of cyclic AMP in hormone-stimulated insulin-secreting beta-cells. Nature 439, 349\u2013352 (2006).","journal-title":"Nature"},{"key":"2098_CR484","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/ng0395-299","volume":"9","author":"J Hager","year":"1995","unstructured":"Hager, J. et al. A missense mutation in the glucagon receptor gene is associated with non-insulin-dependent diabetes mellitus. Nat. Genet. 9, 299\u2013304 (1995).","journal-title":"Nat. Genet."},{"key":"2098_CR485","first-page":"3398","volume":"19","author":"X Wang","year":"2020","unstructured":"Wang, X. et al. Detection and analysis of glucose metabolism-related genes in childhood diabetes using targeted next-generation sequencing: In pediatric population-a hospital-based study. Exp. Ther. Med. 19, 3398\u20133404 (2020).","journal-title":"Exp. Ther. Med."},{"key":"2098_CR486","doi-asserted-by":"publisher","first-page":"725","DOI":"10.2337\/diab.45.6.725","volume":"45","author":"LH Hansen","year":"1996","unstructured":"Hansen, L. H. et al. The Gly40Ser mutation in the human glucagon receptor gene associated with NIDDM results in a receptor with reduced sensitivity to glucagon. Diabetes 45, 725\u2013730 (1996).","journal-title":"Diabetes"},{"key":"2098_CR487","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/dom.13102","volume":"20","author":"DJ Nunez","year":"2018","unstructured":"Nunez, D. J. & D\u2019Alessio, D. Glucagon receptor as a drug target: a witches\u2019 brew of eye of newt (peptides) and toe of frog (receptors). Diabetes Obes. Metab. 20, 233\u2013237 (2018).","journal-title":"Diabetes Obes. Metab."},{"key":"2098_CR488","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1080\/13543776.2020.1769600","volume":"30","author":"C Cheng","year":"2020","unstructured":"Cheng, C., Jabri, S., Taoka, B. M. & Sinz, C. J. Small molecule glucagon receptor antagonists: an updated patent review (2015-2019). Expert Opin. Ther. Pat. 30, 509\u2013526 (2020).","journal-title":"Expert Opin. Ther. Pat."},{"key":"2098_CR489","doi-asserted-by":"publisher","first-page":"170296","DOI":"10.1016\/j.peptides.2020.170296","volume":"127","author":"M Patil","year":"2020","unstructured":"Patil, M., Deshmukh, N. J., Patel, M. & Sangle, G. V. Glucagon-based therapy: past, present and future. Peptides 127, 170296 (2020).","journal-title":"Peptides"},{"key":"2098_CR490","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1080\/13543784.2017.1395020","volume":"26","author":"AJ Scheen","year":"2017","unstructured":"Scheen, A. J., Paquot, N. & Lef\u00e8bvre, P. J. Investigational glucagon receptor antagonists in phase I and II clinical trials for diabetes. Expert Opin. Investig. Drugs 26, 1373\u20131389 (2017).","journal-title":"Expert Opin. Investig. Drugs"},{"key":"2098_CR491","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/dom.12446","volume":"17","author":"RP Kelly","year":"2015","unstructured":"Kelly, R. P. et al. Short-term administration of the glucagon receptor antagonist LY2409021 lowers blood glucose in healthy people and in those with type 2 diabetes. Diabetes Obes. Metab. 17, 414\u2013422 (2015).","journal-title":"Diabetes Obes. Metab."},{"key":"2098_CR492","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.2337\/dc15-1643","volume":"39","author":"CM Kazda","year":"2016","unstructured":"Kazda, C. M. et al. Evaluation of efficacy and safety of the glucagon receptor antagonist LY2409021 in patients with type 2 diabetes: 12- and 24-week phase 2 studies. Diabetes Care 39, 1241\u20131249 (2016).","journal-title":"Diabetes Care"},{"key":"2098_CR493","doi-asserted-by":"publisher","first-page":"e001025","DOI":"10.1136\/bmjdrc-2019-001025","volume":"8","author":"S Lang","year":"2020","unstructured":"Lang, S. et al. Glucagon receptor antagonist upregulates circulating GLP-1 level by promoting intestinal L-cell proliferation and GLP-1 production in type 2 diabetes. BMJ Open Diabetes Res. Care 8, e001025 (2020).","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"2098_CR494","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1073\/pnas.1424934112","volume":"112","author":"M-Y Wang","year":"2015","unstructured":"Wang, M.-Y. et al. Glucagon receptor antibody completely suppresses type 1 diabetes phenotype without insulin by disrupting a novel diabetogenic pathway. Proc. Natl Acad. Sci. USA 112, 2503\u20132508 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2098_CR495","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1111\/dom.13202","volume":"20","author":"J Pettus","year":"2018","unstructured":"Pettus, J. et al. Effect of a glucagon receptor antibody (REMD-477) in type 1 diabetes: a randomized controlled trial. Diabetes Obes. Metab. 20, 1302\u20131305 (2018).","journal-title":"Diabetes Obes. Metab."},{"key":"2098_CR496","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1124\/jpet.108.147009","volume":"329","author":"H Yan","year":"2009","unstructured":"Yan, H. et al. Fully human monoclonal antibodies antagonizing the glucagon receptor improve glucose homeostasis in mice and monkeys. J. Pharmacol. Exp. Ther. 329, 102\u2013111 (2009).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"2098_CR497","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.bbrc.2019.03.148","volume":"512","author":"L Gu","year":"2019","unstructured":"Gu, L. et al. Glucagon receptor antagonism increases mouse pancreatic \u03b4-cell mass through cell proliferation and duct-derived neogenesis. Biochem. Biophys. Res. Commun. 512, 864\u2013870 (2019).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2098_CR498","doi-asserted-by":"publisher","first-page":"110872","DOI":"10.1016\/j.celrep.2022.110872","volume":"39","author":"Y Xi","year":"2022","unstructured":"Xi, Y. et al. Glucagon-receptor-antagonism-mediated \u03b2-cell regeneration as an effective anti-diabetic therapy. Cell Rep. 39, 110872 (2022).","journal-title":"Cell Rep."},{"key":"2098_CR499","doi-asserted-by":"publisher","first-page":"E97","DOI":"10.1152\/ajpendo.00101.2022","volume":"324","author":"K Wang","year":"2023","unstructured":"Wang, K. et al. Glucagon receptor blockage inhibits \u03b2-cell dedifferentiation through FoxO1. Am. J. Physiol. Endocrinol. Metab. 324, E97\u2013E113 (2023).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"2098_CR500","doi-asserted-by":"publisher","first-page":"3920196","DOI":"10.1155\/2020\/3920196","volume":"2020","author":"DM Tanase","year":"2020","unstructured":"Tanase, D. M. et al. The intricate relationship between type 2 diabetes mellitus (T2DM), insulin resistance (IR), and nonalcoholic fatty liver disease (NAFLD). J. Diabetes Res. 2020, 3920196 (2020).","journal-title":"J. Diabetes Res."},{"key":"2098_CR501","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1038\/s41588-023-01497-6","volume":"55","author":"Y Chen","year":"2023","unstructured":"Chen, Y. et al. Genome-wide association meta-analysis identifies 17 loci associated with nonalcoholic fatty liver disease. Nat. Genet. 55, 1640\u20131650 (2023).","journal-title":"Nat. Genet."},{"key":"2098_CR502","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S1097-2765(05)00015-8","volume":"6","author":"MD Michael","year":"2000","unstructured":"Michael, M. D. et al. Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol. Cell 6, 87\u201397 (2000).","journal-title":"Mol. Cell"},{"key":"2098_CR503","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1210\/en.2017-00870","volume":"159","author":"AV Ling","year":"2017","unstructured":"Ling, A. V. et al. FoxO1 is required for most of the metabolic and hormonal perturbations produced by hepatic insulin receptor deletion in male mice. Endocrinology 159, 1253\u20131263 (2017).","journal-title":"Endocrinology"},{"key":"2098_CR504","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12977","volume":"7","author":"N Kubota","year":"2016","unstructured":"Kubota, N. et al. Differential hepatic distribution of insulin receptor substrates causes selective insulin resistance in diabetes and obesity. Nat. Commun. 7, 12977 (2016).","journal-title":"Nat. Commun."},{"key":"2098_CR505","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/nm.2686","volume":"18","author":"M Lu","year":"2012","unstructured":"Lu, M. et al. Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1. Nat. Med. 18, 388\u2013395 (2012).","journal-title":"Nat. Med."},{"key":"2098_CR506","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1172\/JCI20513","volume":"113","author":"Y Horie","year":"2004","unstructured":"Horie, Y. et al. Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas. J. Clin. Invest. 113, 1774\u20131783 (2004).","journal-title":"J. Clin. Invest."},{"key":"2098_CR507","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1073\/pnas.0308617100","volume":"101","author":"B Stiles","year":"2004","unstructured":"Stiles, B. et al. Liver-specific deletion of negative regulator Pten results in fatty liver and insulin hypersensitivity. Proc. Natl Acad. Sci. USA 101, 2082\u20132087 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2098_CR508","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.jhep.2014.09.012","volume":"62","author":"M Peyrou","year":"2015","unstructured":"Peyrou, M. et al. Hepatic PTEN deficiency improves muscle insulin sensitivity and decreases adiposity in mice. J. Hepatol. 62, 421\u2013429 (2015).","journal-title":"J. Hepatol."},{"key":"2098_CR509","doi-asserted-by":"publisher","first-page":"4049","DOI":"10.3390\/jcm9124049","volume":"9","author":"KD Galsgaard","year":"2020","unstructured":"Galsgaard, K. D. The vicious circle of hepatic glucagon resistance in non-alcoholic fatty liver disease. J. Clin. Med. 9, 4049 (2020).","journal-title":"J. Clin. Med."},{"key":"2098_CR510","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.mce.2015.08.013","volume":"415","author":"DH Bedinger","year":"2015","unstructured":"Bedinger, D. H. & Adams, S. H. Metabolic, anabolic, and mitogenic insulin responses: a tissue-specific perspective for insulin receptor activators. Mol. Cell. Endocrinol. 415, 143\u2013156 (2015).","journal-title":"Mol. Cell. Endocrinol."},{"key":"2098_CR511","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/ERC-12-0324","volume":"20","author":"S Djiogue","year":"2013","unstructured":"Djiogue, S. et al. Insulin resistance and cancer: the role of insulin and IGFs. Endocr. Relat. Cancer 20, R1\u2013R17 (2013).","journal-title":"Endocr. Relat. Cancer"},{"key":"2098_CR512","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nrc3720","volume":"14","author":"RC Baxter","year":"2014","unstructured":"Baxter, R. C. IGF binding proteins in cancer: mechanistic and clinical insights. Nat. Rev. Cancer 14, 329\u2013341 (2014).","journal-title":"Nat. Rev. Cancer"},{"key":"2098_CR513","first-page":"2808","volume":"18","author":"Y Gong","year":"2014","unstructured":"Gong, Y., Dou, L.-J. & Liang, J. Link between obesity and cancer: role of triglyceride\/free fatty acid cycling. Eur. Rev. Med. Pharmacol. Sci. 18, 2808\u20132820 (2014).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"2098_CR514","doi-asserted-by":"publisher","first-page":"R225","DOI":"10.1530\/ERC-12-0203","volume":"19","author":"DP Rose","year":"2012","unstructured":"Rose, D. P. & Vona-Davis, L. The cellular and molecular mechanisms by which insulin influences breast cancer risk and progression. Endocr. Relat. Cancer 19, R225\u2013R241 (2012).","journal-title":"Endocr. Relat. Cancer"},{"key":"2098_CR515","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3390\/biom11010125","volume":"11","author":"F Biello","year":"2021","unstructured":"Biello, F. et al. Insulin\/IGF axis in breast cancer: clinical evidence and translational insights. Biomolecules 11, 125 (2021).","journal-title":"Biomolecules"},{"key":"2098_CR516","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/BF00052777","volume":"6","author":"E Giovannucci","year":"1995","unstructured":"Giovannucci, E. Insulin and colon cancer. Cancer Causes Control CCC 6, 164\u2013179 (1995).","journal-title":"Cancer Causes Control CCC"},{"key":"2098_CR517","doi-asserted-by":"publisher","first-page":"3603","DOI":"10.1158\/1078-0432.CCR-21-4272","volume":"28","author":"G Chakraborty","year":"2022","unstructured":"Chakraborty, G. et al. The impact of PIK3R1 mutations and insulin-PI3K-glycolytic pathway regulation in prostate cancer. Clin. Cancer Res. 28, 3603\u20133617 (2022).","journal-title":"Clin. Cancer Res."},{"key":"2098_CR518","doi-asserted-by":"publisher","first-page":"29501","DOI":"10.18632\/oncotarget.15704","volume":"8","author":"X Qu","year":"2017","unstructured":"Qu, X. et al. Update of IGF-1 receptor inhibitor (ganitumab, dalotuzumab, cixutumumab, teprotumumab and figitumumab) effects on cancer therapy. Oncotarget 8, 29501\u201329518 (2017).","journal-title":"Oncotarget"},{"key":"2098_CR519","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.3390\/cancers15041287","volume":"15","author":"G Liu","year":"2023","unstructured":"Liu, G., Zhu, M., Zhang, M. & Pan, F. Emerging role of IGF-1 in prostate cancer: a promising biomarker and therapeutic target. Cancers 15, 1287 (2023).","journal-title":"Cancers"},{"key":"2098_CR520","doi-asserted-by":"publisher","first-page":"819128","DOI":"10.3389\/fonc.2022.819128","volume":"12","author":"Y Peng","year":"2022","unstructured":"Peng, Y., Wang, Y., Zhou, C., Mei, W. & Zeng, C. PI3K\/Akt\/mTOR pathway and its role in cancer therapeutics: are we making headway?. Front. Oncol 12, 819128 (2022).","journal-title":"Front. Oncol"},{"key":"2098_CR521","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1146\/annurev-med-052218-125823","volume":"71","author":"L Yehia","year":"2020","unstructured":"Yehia, L., Keel, E. & Eng, C. The clinical spectrum of PTEN mutations. Annu. Rev. Med. 71, 103\u2013116 (2020).","journal-title":"Annu. Rev. Med."},{"key":"2098_CR522","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.semcancer.2019.02.001","volume":"59","author":"V \u00c1lvarez-Garcia","year":"2019","unstructured":"\u00c1lvarez-Garcia, V., Tawil, Y., Wise, H. M. & Leslie, N. R. Mechanisms of PTEN loss in cancer: it\u2019s all about diversity. Semin. Cancer Biol. 59, 66\u201379 (2019).","journal-title":"Semin. Cancer Biol."},{"key":"2098_CR523","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/JP9.0000000000000125","volume":"6","author":"Y Ma","year":"2023","unstructured":"Ma, Y., Wang, X., Zhao, H. & Jiao, Y. Molecular alterations and therapeutic targets in pancreatic neuroendocrine tumors. J. Pancreatol. 6, 119 (2023).","journal-title":"J. Pancreatol."},{"key":"2098_CR524","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-54599-4","volume":"14","author":"JY Kim","year":"2024","unstructured":"Kim, J. Y. et al. Somatostatin receptor 2 (SSTR2) expression is associated with better clinical outcome and prognosis in rectal neuroendocrine tumors. Sci. Rep. 14, 4047 (2024).","journal-title":"Sci. Rep."},{"key":"2098_CR525","first-page":"11223","volume":"13","author":"J-H He","year":"2021","unstructured":"He, J.-H. et al. SSTR2 is a prognostic factor and a promising therapeutic target in glioma. Am. J. Transl. Res. 13, 11223\u201311234 (2021).","journal-title":"Am. J. Transl. Res."},{"key":"2098_CR526","doi-asserted-by":"publisher","first-page":"822","DOI":"10.2741\/2722","volume":"13","author":"T Florio","year":"2008","unstructured":"Florio, T. Molecular mechanisms of the antiproliferative activity of somatostatin receptors (SSTRs) in neuroendocrine tumors. Front. Biosci. J. Virtual Libr. 13, 822\u2013840 (2008).","journal-title":"Front. Biosci. J. Virtual Libr."},{"key":"2098_CR527","doi-asserted-by":"publisher","first-page":"104707","DOI":"10.1016\/j.neuint.2020.104707","volume":"135","author":"A Akhtar","year":"2020","unstructured":"Akhtar, A. & Sah, S. P. Insulin signaling pathway and related molecules: role in neurodegeneration and Alzheimer\u2019s disease. Neurochem. Int. 135, 104707 (2020).","journal-title":"Neurochem. Int."},{"key":"2098_CR528","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.molmet.2018.01.013","volume":"9","author":"S Logan","year":"2018","unstructured":"Logan, S. et al. Insulin-like growth factor receptor signaling regulates working memory, mitochondrial metabolism, and amyloid-\u03b2 uptake in astrocytes. Mol. Metab. 9, 141\u2013155 (2018).","journal-title":"Mol. Metab."},{"key":"2098_CR529","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1523\/JNEUROSCI.21-08-02561.2001","volume":"21","author":"L Gasparini","year":"2001","unstructured":"Gasparini, L. et al. Stimulation of beta-amyloid precursor protein trafficking by insulin reduces intraneuronal beta-amyloid and requires mitogen-activated protein kinase signaling. J. Neurosci. 21, 2561\u20132570 (2001).","journal-title":"J. Neurosci."},{"key":"2098_CR530","doi-asserted-by":"publisher","first-page":"RC221","DOI":"10.1523\/JNEUROSCI.22-10-j0001.2002","volume":"22","author":"L Xie","year":"2002","unstructured":"Xie, L. et al. Alzheimer\u2019s beta-amyloid peptides compete for insulin binding to the insulin receptor. J. Neurosci. 22, RC221 (2002).","journal-title":"J. Neurosci."},{"key":"2098_CR531","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.neurobiolaging.2008.04.002","volume":"31","author":"AM Moloney","year":"2010","unstructured":"Moloney, A. M. et al. Defects in IGF-1 receptor, insulin receptor and IRS-1\/2 in Alzheimer\u2019s disease indicate possible resistance to IGF-1 and insulin signalling. Neurobiol. Aging 31, 224\u2013243 (2010).","journal-title":"Neurobiol. Aging"},{"key":"2098_CR532","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1042\/bj2960015","volume":"296","author":"C Sutherland","year":"1993","unstructured":"Sutherland, C., Leighton, I. A. & Cohen, P. Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling. Biochem. J. 296, 15\u201319 (1993).","journal-title":"Biochem. J."},{"key":"2098_CR533","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.neuroscience.2004.05.036","volume":"127","author":"H Kyoung Pyo","year":"2004","unstructured":"Kyoung Pyo, H., Lovati, E., Pasinetti, G. M. & Ksiezak-Reding, H. Phosphorylation of tau at THR212 and SER214 in human neuronal and glial cultures: the role of AKT. Neuroscience 127, 649\u2013658 (2004).","journal-title":"Neuroscience"},{"key":"2098_CR534","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.neuropharm.2009.11.010","volume":"58","author":"L Munoz","year":"2010","unstructured":"Munoz, L. & Ammit, A. J. Targeting p38 MAPK pathway for the treatment of Alzheimer\u2019s disease. Neuropharmacology 58, 561\u2013568 (2010).","journal-title":"Neuropharmacology"},{"key":"2098_CR535","doi-asserted-by":"publisher","first-page":"213","DOI":"10.18388\/pb.2018_133","volume":"64","author":"M Kossut","year":"2018","unstructured":"Kossut, M., \u0141ukomska, A., Dobrza\u0144ski, G. & Liguz-L\u0119cznar, M. Somatostatin receptors in the brain. Postepy Biochem 64, 213\u2013221 (2018).","journal-title":"Postepy Biochem"},{"key":"2098_CR536","doi-asserted-by":"publisher","first-page":"102270","DOI":"10.1016\/j.arr.2024.102270","volume":"96","author":"VN Almeida","year":"2024","unstructured":"Almeida, V. N. Somatostatin and the pathophysiology of Alzheimer\u2019s disease. Ageing Res. Rev. 96, 102270 (2024).","journal-title":"Ageing Res. Rev."},{"key":"2098_CR537","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/0026-0495(90)90225-2","volume":"39","author":"PJ Riekkinen","year":"1990","unstructured":"Riekkinen, P. J. & Pitk\u00e4nen, A. Somatostatin and epilepsy. Metabolism 39, 112\u2013115 (1990).","journal-title":"Metabolism"},{"key":"2098_CR538","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0304-3940(98)00698-3","volume":"255","author":"D Grouselle","year":"1998","unstructured":"Grouselle, D. et al. Loss of somatostatin-like immunoreactivity in the frontal cortex of Alzheimer patients carrying the apolipoprotein epsilon 4 allele. Neurosci. Lett. 255, 21\u201324 (1998).","journal-title":"Neurosci. Lett."},{"key":"2098_CR539","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1038\/s41380-021-01368-8","volume":"27","author":"N Watamura","year":"2022","unstructured":"Watamura, N. et al. Somatostatin-evoked A\u03b2 catabolism in the brain: Mechanistic involvement of \u03b1-endosulfine-KATP channel pathway. Mol. Psychiatry 27, 1816\u20131828 (2022).","journal-title":"Mol. Psychiatry"},{"key":"2098_CR540","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.mce.2008.01.014","volume":"286","author":"E Burgos-Ramos","year":"2008","unstructured":"Burgos-Ramos, E. et al. Somatostatin and Alzheimer\u2019s disease. Mol. Cell. Endocrinol. 286, 104\u2013111 (2008).","journal-title":"Mol. Cell. Endocrinol."},{"key":"2098_CR541","volume":"4","author":"E Moggia","year":"2017","unstructured":"Moggia, E. et al. Pharmacological interventions for acute pancreatitis. Cochrane Database Syst. Rev. 4, CD011384 (2017).","journal-title":"Cochrane Database Syst. Rev."},{"key":"2098_CR542","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.pan.2022.07.011","volume":"22","author":"SJ Pandol","year":"2022","unstructured":"Pandol, S. J. & Gottlieb, R. A. Calcium, mitochondria and the initiation of acute pancreatitis. Pancreatology 22, 838\u2013845 (2022).","journal-title":"Pancreatology"},{"key":"2098_CR543","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1007\/s10620-019-05863-5","volume":"65","author":"S Nadella","year":"2020","unstructured":"Nadella, S. et al. Cholecystokinin receptor antagonist therapy decreases inflammation and fibrosis in chronic pancreatitis. Dig. Dis. Sci. 65, 1376\u20131384 (2020).","journal-title":"Dig. Dis. Sci."},{"key":"2098_CR544","doi-asserted-by":"publisher","first-page":"611","DOI":"10.3390\/pharmaceutics16050611","volume":"16","author":"V Ciofoaia","year":"2024","unstructured":"Ciofoaia, V. et al. The role of a cholecystokinin receptor antagonist in the management of chronic pancreatitis: a phase 1 trial. Pharmaceutics 16, 611 (2024).","journal-title":"Pharmaceutics"},{"key":"2098_CR545","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.2174\/0929867324666170619104801","volume":"26","author":"HH Wang","year":"2019","unstructured":"Wang, H. H., Portincasa, P. & Wang, D. Q.-H. Update on the molecular mechanisms underlying the effect of cholecystokinin and cholecystokinin-1 receptor on the formation of cholesterol gallstones. Curr. Med. Chem. 26, 3407\u20133423 (2019).","journal-title":"Curr. Med. Chem."},{"key":"2098_CR546","doi-asserted-by":"publisher","first-page":"71","DOI":"10.5056\/jnm.2010.16.1.71","volume":"16","author":"S-Y Park","year":"2010","unstructured":"Park, S.-Y. et al. Association of CCK(1) receptor gene polymorphisms and irritable bowel syndrome in Korean. J. Neurogastroenterol. Motil. 16, 71\u201376 (2010).","journal-title":"J. Neurogastroenterol. Motil."},{"key":"2098_CR547","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1038\/sj.bjp.0705769","volume":"141","author":"G Varga","year":"2004","unstructured":"Varga, G., B\u00e1lint, A., Burghardt, B. & D\u2019Amato, M. Involvement of endogenous CCK and CCK1 receptors in colonic motor function. Br. J. Pharmacol. 141, 1275\u20131284 (2004).","journal-title":"Br. J. Pharmacol."},{"key":"2098_CR548","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/nrneph.2016.145","volume":"12","author":"F Artunc","year":"2016","unstructured":"Artunc, F. et al. The impact of insulin resistance on the kidney and vasculature. Nat. Rev. Nephrol. 12, 721\u2013737 (2016).","journal-title":"Nat. Rev. Nephrol."},{"key":"2098_CR549","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1210\/er.2016-1078","volume":"37","author":"G Pujadas","year":"2016","unstructured":"Pujadas, G. & Drucker, D. J. Vascular biology of glucagon receptor superfamily peptides: mechanistic and clinical relevance. Endocr. Rev. 37, 554\u2013583 (2016).","journal-title":"Endocr. Rev."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-024-02098-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-024-02098-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-024-02098-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T18:03:40Z","timestamp":1739469820000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-024-02098-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,14]]},"references-count":549,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2098"],"URL":"https:\/\/doi.org\/10.1038\/s41392-024-02098-3","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,14]]},"assertion":[{"value":"20 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39"}}